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CHOLESCINTIGRAPHY AFTER ENDOSCOPIC PAPILLOTOMY IN PATIENTS 
WITH AN INTACT GALLBLADDER. Michael A. Price, Michael C. 
Bennick, Adrian Reuben, John Dobbins, and Morton I. Burrell. 
Departments of Diagnostic Radiology and Internal Medicine, 
Section of Gastroenterology, Yale University School of 
Medicine, New Haven, CT. 
The aim of this study was to determine baseline 
cholescintigraphic findings in persons with an intact 
gallbladder and an ablated sphincter of Oddi. This 
information allows assessment of: 1) the reliability of 
cholescintigraphy for diagnosing acute cholecystitis in this 
population, and 2) the contribution of the sphincter of Oddi 
to the physiological process of gallbladder filling in 
humans. Five subjects with an intact gallbladder, who had 
previously undergone endoscopic papillotomy, were studied 
according to the following protocol: 1) Quantitative 
cholescintigraphy was performed with 99mTc-DISIDA (5 mCi). 
2) Evidence of a patent papillotomy was sought, using 
ultrasonography and plain abdominal radiography for 
detection of biliary air, and barium swallow for detection 
of duodenal-biliary reflux of contrast. Biliary air was 
demonstrated by plain film in two subjects (40%) and by 




occurred only in the two subjects (40%) who had evidence of 
biliary air on plain film. The gallbladder was seen by 
cholescintigraphy in three (60%) of the five subjects, 
including one of the two subjects (50%) with supportive 
evidence of a patent papillotomy. Additional data are 
necessary before conclusions can be drawn, but our 
preliminary results suggest that: 1) Visualization of the 
gallbladder by cholescintigraphy may occur in a patient 
following endoscopic papillotomy. In such patients, the 
reliability of cholescintigraphy for diagnosing cystic duct 
obstruction (radiologic confirmation of clinically suspected 
acute cholecystitis) cannot yet be determined. 2) 
Gallbladder filling can occur even in the setting of a 
non-functional sphincter of Oddi. Thus, gallbladder filling 
probably depends upon other physiologic mechanisms, in 
addition to any role played by sphincter contraction. 
NOTE: An additional subject participated in the study after this 
abstract was submitted for publication. The thesis includes the data 
from all six subjects. 
* 
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This investigation was performed in order to determine 
baseline cholescintigraphic findings in persons with an 
intact gallbladder and an ablated sphincter of Oddi. The 
goals of this study were: 1) to ascertain whether chole- 
scintigraphy is likely to be a reliable test for acute 
cholecystitis in this population (as it is in patients with 
an intact sphincter of Oddi), and 2) to elucidate the role 
of the sphincter of Oddi in the process of gallbladder 
filling in humans. 
Cholescintigraphy employs radiolabelled iminodiacetic 
acid (IDA) compounds to provide both an assessment of 
hepatic uptake and excretory function, and a visual demon¬ 
stration of hepatobiliary anatomy. This test is often used 
as the primary diagnostic procedure in suspected cases of 
acute cholecystitis (in patients with an otherwise intact 
biliary tree). The efficacy of this test has not been 
evaluated, however, in patients who have undergone endo¬ 
scopic papillotomy. This is a procedure in which the 
sphincter of Oddi is severed, usually to facilitate removal 
of gallstones obstructing the common bile duct. 
A second facet of this study was to examine the mech¬ 
anism by which the human gallbladder fills, as the contri¬ 
bution of the sphincter of Oddi to this process is still 
unresolved. One theory proposes that the gallbladder fills 




of a pressure gradient from the common duct. An alternative 
viewpoint holds that filling depends upon occlusion of the 
terminal common bile duct by the sphincter of Oddi (and/or 
possibly the duodenal musculature), thereby forcing bile to 
flow into the gallbladder. If this latter theory is correct, 
the loss of sphincter contractility after papillotomy would 
allow bile to flow preferentially into the duodenum instead 
of the gallbladder. Impaired filling would thus cause non¬ 
visualization of the gallbladder by cholescintigraphy, 
giving a false positive test for cystic duct obstruction. 
The Human Biliary System: Basic Structure and Function: 
The biliary system consists of the gallbladder and bile 
ducts. The gallbladder is a small sac which stores and 
concentrates bile synthesized and secreted by the liver. 
Ducts connect the liver, gallbladder, and duodenum, allowing 
movement of bile between these organs. Bile is an aqueous 
solution of electrolytes, organic anions, bile acids, 
lipids, proteins, and products of hepatic metabolism, which 
fulfills both excretory and digestive functions. Cholesterol 
and metabolites of endogenous and exogenous substances are 
eliminated in the bile. Bile acids aid in the intestinal 
absorption of dietary lipids by solubilizing products of 
digestion in mixed micelles that are readily carried to the 
mucosal surface of enterocytes.1' 3 
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Bile is secreted from hepatocytes into microscopic 
channels known as bile canaliculi. These structures coalesce 
to form successively larger tubules (bile ductules and 
intrahepatic bile ducts) that eventually emerge from the 
liver as the right and left hepatic ducts. These converge to 
form the common hepatic duct, to which the cystic duct joins 
the gallbladder to the biliary tract. The mucosa of the 
proximal cystic duct is arranged into crescentic folds known 
as the spiral valves of Heister, which may participate in 
the regulation of bile flow into and out of the gallbladder. 
The common bile duct arises from the union of the cystic and 
common hepatic ducts. It courses through the duodenal muscu¬ 
lature, and opens into the duodenum at the papilla of Vater. 
The main pancreatic duct joins the common bile duct at the 
ampulla of Vater (in the most common anatomic configura¬ 
tion), to form a single orifice at the papilla. The terminal 
common duct and ampulla are encircled by the sphincter of 
Oddi, a band of muscle tissue anatomically and embryologi- 
cally distinct from the duodenal musculature.3'6 Figure 1 
depicts the anatomy of the human biliary tract. 
Bile enters the gut mainly in response to the presence 
of fat in the duodenum. This stimulus triggers the secretion 
of the hormone cholecystokinin (CCK) from intestinal mucosal 
cells. CCK is the primary mediator of post-prandial biliary 
motility; its action induces contraction of the gallbladder 
and relaxation of the sphincter of Oddi, which results in 
















Figure 1: Anatomy of the human biliary system (modified- 
from Hogan, Dodds, and Geenen, 1983).4 
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pathways, additional gut hormones (including motilin, 
secretin, pancreatic polypeptide, vasoactive intestinal 
polypeptide, and glucagon), enkephalins, and prostaglandins 
also influence biliary motility, although their precise 
physiologic roles have not been fully characterized.3,4 
The Pathophysiology of Gallstone Disease: 
Gallstones are solid concretions which form when 
substances such as cholesterol, bilirubin, calcium, and 
proteins precipitate out of solution in bile. Stones usually 
form within the gallbladder, but also develop in the bile 
ducts in rare instances. Gallstones are quite prevalent in 
Western countries, occurring in about 10-20% of adults in 
the United States. Three major types of gallstones exist: 
cholesterol stones, mixed stones, and pigment stones. 
Cholesterol and mixed stones, which consist primarily of 
cholesterol, are common in Western populations. Pigment 
stones, composed mainly of calcium bilirubinate, are more 
prevalent in Asian countries. The exact pathogenesis of 
gallstones is not entirely clear, and probably depends upon 
multiple factors. Supersaturation of bile with cholesterol 
is a prerequisite for cholesterol stone formation. Risk 
factors associated with the development of cholesterol gall¬ 
stones include: 1) advanced age, 2) female sex, 3) obesity, 
4) use of certain drugs (clofibrate, thiazide diuretics, and 
estrogens), and 5) certain diseases (e.g., ileal disorders. 
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cystic fibrosis, diabetes mellitus, and hyperlipidemia). 
Conditions which may predispose to the development of 
pigment stones include alcoholic cirrhosis, biliary infec¬ 
tions, and chronic hemolysis. Genetic and dietary factors 
may also play a role in gallstone pathogenesis.3•7'9 
Gallstones may remain clinically silent for years. A 
study of 123 asymptomatic persons with gallstones detected 
by screening found only an 18% probability of developing 
resultant biliary symptoms or complications over a 20 year 
period.10 However, cholelithiasis can lead to a variety of 
illnesses. Intermittent obstruction of the cystic duct by a 
stone can cause episodes of biliary colic, typically 
manifested by right upper quadrant abdominal pain. Over 
time, stones in the gallbladder may cause chronic chole¬ 
cystitis, a condition characterized by chronic inflammatory 
changes in the gallbladder wall. Impaction of a stone in the 
cystic duct is the most common cause of acute cholecystitis, 
an acute inflammation of the gallbladder which usually 
necessitates cholecystectomy. Stones may also lodge in the 
bile ducts (choledocholithiasis) with resultant obstruction, 
possibly leading to ascending cholangitis and/or pancrea¬ 
titis. These conditions can be life-threatening, and may 
require interventional therapeutic measures to relieve the 
obstruction. Gallstones are also associated with the 
development of carcinoma of the gallbladder.3 ■ 8 • 9 
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Surgical Management of Biliary Obstruction: 
Until the 1970's, surgery was the only interventional 
form of therapy available for biliary obstruction. Operative 
procedures for relieving common duct obstruction include 1) 
lateral choledochotomy (common bile duct exploration) and 
choledocholithotomy,1 1 2) sphincter ablation by transduo- 
denal sphincterotomy or sphincteroplasty,12 and 3) biliary 
bypass techniques such as choledocho- and cholecystoenter- 
ostomy.13 Patients with an in situ gallbladder presenting 
with choledocholithiasis usually undergo combined chole¬ 
cystectomy and common bile duct exploration. 
The risks of biliary surgery are minimal in young and 
healthy patients. A large American surgical series of 11,808 
patients reported a 0.1% mortality for cholecystectomy among 
patients younger than 50 years operated on for chronic 
cholecystitis, and a 0.9% mortality for similar patients 
undergoing cholecystectomy with common duct exploration.14 A 
recent international survey reported overall mortality rates 
(among all age groups) of 0.6% for cholecystectomy alone and 
4.4% for cholecystectomy with common duct exploration.15 
Reported mortality rates for all age groups undergoing 
surgical sphincterotomy vary from 0-13%, with a mean of 4.6% 
(total 1061 cases), and those for choledochoduodenostomy 
range from 0-8%, with a mean of 3.0% (total 733 cases).16 
Peri-operative morbidity and mortality rise dramati¬ 
cally, however, among patients with advanced age and/or 
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coexisting illnesses, and in cases requiring emergency 
surgery.17"22 For various biliary procedures, surgical 
mortality rates of 4.0-16.2% have been reported in patients 
over the age of 60.18"21 One study noted a 28.6% mortality 
rate for combined cholecystectomy and common bile duct 
exploration in patients aged 70 and over.23 An analysis of 
several series on elderly patients quoted average mortality 
rates of 4.4% for elective biliary surgery, as compared to 
16.7% for similar operations performed emergently.22 Studies 
correlating surgical mortality with specific risk parameters 
(including age, underlying malignancy, anemia, malnutrition, 
diabetes mellitus, impaired renal function, hyperbilirubin¬ 
emia, elevated alkaline phosphatase, and leukocytosis) have 
shown a tremendous increase in mortality as the number of 
risk factors increases.20,21 Thus, while biliary tract 
surgery is quite safe in younger patients in relatively good 
health, operative intervention becomes hazardous in elderly 
persons with complicating illnesses, especially in situa¬ 
tions necessitating emergency surgery. 
Endoscopic Papillotomy: 
In 1974, Classen and Demling24 in Germany and Kawai et 
al.2B in Japan independently introduced the technique of 
endoscopic papillotomy (also called endoscopic sphincter¬ 
otomy) for the treatment of common duct stones. As an 
alternative to surgery, this modality has proven safe and 
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effective in patients posing a high operative risk. Endo¬ 
scopic papillotomy is a therapeutic extension of endoscopic 
retrograde cholangiopancreatography (ERCP), an invasive 
method of imaging the biliary tree and pancreatic duct. 
Using a fiberoptic endoscope introduced orally to directly 
view the papilla of Vater, the endoscopist cannulates the 
orifice with a catheter passed through a channel in the 
endoscope, and injects radiographic contrast material. The 
resultant cholangiogram outlines biliary anatomy and demon¬ 
strates the presence of stones or other pathology (see 
Figures 6, 12, 14, 20, 24, & 28). If indicated by findings 
on ERCP, section of the sphincter of Oddi can be performed 
endoscopically, by use of a papillotome (or sphincterotome). 
This instrument consists of a Teflon catheter surrounding a 
wire snare, one arm of which extrudes from the catheter 
lumen for a short distance near the distal end (see Figure 
2). Under tension, the catheter flexes in the form of a bow, 
with the wire protruding like a "bowstring". After cannu- 
lating the papilla of Vater, positioning the papillotome 
within the common bile duct, and tensing the wire, the 
endoscopist applies electric current to the wire, creating a 
10-20 mm incision, which transects the muscle fibers of the 
papillary and common bile duct sphincters.26'31 Sphincter 
function is thus obliterated, producing a potentially 
permanent opening from the common bile duct into the 
duodenum. Figure 3 is a schematic representation of the 
technique of endoscopic papillotomy. 
' 
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Figure 2: Instruments used for endoscopic papillotomy and 
gallstone extraction: (from L to R), Zimmon papillotome, 
Dormia basket catheter, inflated Fogarty balloon catheter. 
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Figure 3: Schematic representation of endoscopic 
papillotomy and stone extraction: (A) Papillotome is 
inserted into the common bile duct. (B) Tension is applied 
to the wire, flexing the catheter and bringing the wire, 
into position for cutting. (C) Diathermy current is 
applied to the wire, incising the sphincter. (D) A stone 




Figure 4: ERCP films 
demonstrating: 
(A) extraction of two 
stones from the common 
duct with a Dormia 
basket (Subject #2). 
(B) A Fogarty balloon 
catheter inflated in 




Following papillotomy, endoscopists often allowed 
ductal stones to pass spontaneously through the enlarged 
choledochoduodenal orifice, and performed a repeat ERCP to 
check for clearance of stones from the common duct.28■32"35 
Direct removal of choledochal stones has now become common 
practice, since this reduces the chance for complications 
due to retained calculi, and obviates the need for a second 
endoscopic examination.31 Instruments employed for stone 
extraction include: 1) a collapsible wire basket used to 
capture and retract stones26 - 28 ■ 3 1' 3 3 * 3 7 * 3 8 (see Figures 2 & 
4A); and 2) a balloon-tipped catheter used to pull stones 
out of the duct3 1 ■ 37 ■ 38 (see Figures 2 & 4B). These devices 
are effective for removing both single and multiple stones. 
Immediately following extraction, a repeat cholangiogram 
verifies successful clearance of stones from the duct. 
Since its introduction in 1974, endoscopic papillotomy 
has become widely accepted as an alternative or adjunct to 
surgery in the management of certain forms of obstructive 
biliary disease. Choledocholithiasis remains the most common 
indication for this procedure, accounting for 80-94% of all 
cases in published series. 2 8 * 3 3 " 37 • 39 ' 45 Additionally, this 
technique has proved successful for: 1) treating biliary 
obstruction due to benign disorders such as papillary 
stenosis, 2 7 - 2 8 - 3 0 • 3 3 - 3 7 • 40~43 - 45 common bile duct stric¬ 
tures,35-42 hydatid disease,35-46 and ascariasis;40 2) 
treatment of chronic pancreatitis35 and gallstone pancrea¬ 
titis ,30 • 41 ■ 47' 49 and 3) relief of obstructive jaundice 
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prior to surgery for carcinomas of the ampulla, bile ducts, 
and pancreas.27,30,34-37.41-43 
Clinical series from multiple international centers 
have reported good results with endoscopic papillotomy. 
Transection of the sphincter of Oddi is achieved in 81-100% 
of attempted cases26 "30 * 3 2 - 3 5 - 3 9 - 44,47,5o- 55 (see Table 1). 
These figures have improved with increased experience; 
papillotomy is currently successful in over 90% of cases.31 
Failure to perform the procedure is usually due to 1) an 
inaccessible papilla in patients with pyloric or duodenal 
stenosis, juxta-ampullary diverticula, or following Bilroth 
II gastrectomy or other surgical procedures, 2) technical 
failure of cannulation, or 3) an uncooperative 
patient.28,31,38*56 Successful papillotomy allows clearance 
of obstructing stones in 85-99% of cases of choledocho- 
lithiasis. 2 6 - 2 9 • 32 • 3 3 * 3 9 ‘43 • 45 • 4 7 * 5 0 • 5 1 • 53 • 55 The overall 
success rate of endoscopic papillotomy for treatment of 
common duct stones is thus 76-97%2 s.29-31-33.39-44.47.50.55 
(see Table 2). 
Endoscopic papillotomy is a relatively safe technique 
when performed by an experienced endoscopist. The reported 
morbidity resulting from the procedure ranges from 3-20%, 
with most studies around 7-10%.27‘ 3 7 * 3 9 " 4 5 * 4 7 • 50 " 55 The most 
commonly encountered complications include 1) hemorrhage at 
the incision site, 2) cholangitis (resulting from inadequate 
biliary drainage, and usually due to impacted stones), 3) 
pancreatitis, 4) retroperitoneal duodenal perforation, and 
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Table Is Reported success rates of attempted endoscopic papillotomy in 
multiple series. 





Classen & Safrany 1975 Hamburg/Munster 59 50 (84.7%) 
Safrany 1977 Munster 265 243 (91.7%) 
Koch et al. 1977 Erlangen 267 254 (95.1%) 
Safrany 1978 15 Internatl 3853 3618 (93.9%) 
Siefert 1978 9 German 955 880 (92.1%) 
Reiter 1978 9 German 1499 1403 (93.6%) 
Ligoury & Loriga 1978 Paris 155 144 (92.5%) 
Montori et al. 1979 8 Italian 239 194 (81.2%) 
Makajima et al. 1979 25 Japanese 485 468 (96.5%) 
Cotton 1980 London 134 129 (96.3%) 
Geenen et al. 1981 21 U.S. 1250 1113 (89.0%) 
Sieqel 1981 New York 267 258 (96.6%) 
Viceconte et al. 1981 Rome 296 255 (86.1%) 
Cotton & Vallon 1981 14 British 679 590 (86.9%) 
Mee et al. 1981 London 71 69 (97.2%) 
Cotton &. Vallon 1982 London 71 70 (98.6%) 
Kawai et al. 1983 Kyoto 496 486 (98.0%) 
Roberts-Thompson 1984 Melbourne 322 300 (93.2%) 
Escourrou et al. 1984 Toulouse 443 407 (91.7%) 
Neoptolemos et al. 1984 Leicester 100 98 (98.0%) 
Davidson et al. 1988 Leicester 106 105 (99.0%) 
Rosseland & Solhauq 1988 Norway/Sweden 75 75 (100%) 
NOTE: "Success" refers only to cannulation of the papilla and incision 
of the sphincter of Oddi. See Table 2 for statistics on the success 
rates of stone extraction. 
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Table 2: Reported success rates of common i bile duct stone removal 
following endoscopic papillotomy. 
Att Succ Clear Succ Overall 
Investiqator(s) Date Pap Pap Stone Rate Success 
Classen & Safrany 1975 — 39 33 84.6% — 
Safrany 1977 — 185 173 93.5% — 
Koch et al. 1977 231 222 192 86.5% 83.1% 
Safrany 1978 -- 3070 2779 90.5% -- 
Ligoury & Loriga 1978 145 — 120 — 82.8% 
Montori et al. 1979 -- 155 149 96.1% -- 
Nakajima et al. 1979 446 430 370 86.0% 83.0% 
Cotton 1980 134 129 119 92.2% 88.8% 
Siegel 1981 235 230 228 99.1% 97.0% 
Viceconte et al. 1981 238 205 195 95.1% 81.9% 
Cotton & Vallon 1981 679 590 513 86.9% 75.6% 
Mee et al. 1981 71 69 65 94.2% 91.5% 
Cotton & Vallon 1982 71 70 61 87.1% 85.9% 
Kawai et al. 1983 422 413 398 96.4% 94.3% 
Neoptolemos et al. 1984 100 98 91 92.9% 91.0% 
Rosseland & Solhauq 1988 75 75 71 94.6% 94.6% 
Abbreviations: Att Pap = Number of papillotomies attempted for treatment 
of choledocholithisis; Succ Pap = Number of attempts in which section of 
the sphincter of Oddi was achieved; Clear Stone = Number of cases in 
which spontaneous passage or direct extraction of common duct stones was 
confirmed; Succ Rate = Percentage of cases in which clearance of stones 
was confirmed following a successful papillotomy; Overall Success = 
Percentage of all attempted cases (both successful and failed 
papillotomies) in which clearance of stones from the common duct was 
achieved; — = Data not given. 
L/ 
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5) impaction of an extraction basket at the papilla. 
Immediate complications usually respond to supportive 
treatment, necessitating emergency surgery in from 0.5-5.7% 
(average 1-2.5%) of patients after successful papil¬ 
lotomy .27' 3 5 * 3 7 * 3 9 ‘ 45•47■49‘52•54• 55 Mortality from this 
procedure varies from 0-4.7%, with most large studies 
reporting death rates of 0.8-1.7%.27 ‘ 3°* 32"37■39"45•47•50 - 55 
Table 3 provides data regarding the complication and death 
rates of endoscopic papillotomy reported in several series. 
Comparison of success and complication rates of 
surgical versus endoscopic treatment is difficult, mainly 
because of significant differences in patient selec¬ 
tion .3 1 - 56' 59 The majority of persons referred for endo¬ 
scopic papillotomy are old and/or relatively ill, and thus 
represent poor candidates for surgery. In such high risk 
patients, endoscopic biliary decompression avoids the 
surgical complications related to laparotomy, duodenotomy, 
and general anesthesia.32 ■ 34 ■ 37 • 42 ■ 55 In young and healthy 
patients the morbidity and mortality of surgical and endo¬ 
scopic therapy are similar,35 * 41 • 47 ■ 59 and the preferred 
form of treatment is often determined by the individual 
concerns of the patient and physician. Endoscopic papil¬ 
lotomy offers the short term advantages of lower cost, 
avoidance of surgical risk, and shorter hospitalization 
time. However, the potential long-term consequences of 1) 
sphincter ablation, and 2) leaving behind a stone filled 
gallbladder, are undetermined. 
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Table 3r Reported early morbidity and mortality from endoscopic 
papillotomy. 
Investiqator(s) Date N Comp Surg Death 
Safrany 1977 243 24 (9.9%) 6 (2 5%) 3 (1.2%) 
Koch et al. 1977 254 19 (7.5%) 8 (3 1%) 2 (0.8%) 
Safrany 1978 3618 254 (7.0%) 83 (2 3%) 50 (1.4%) 
Siefert 1978 880 64 (7.3%) 19 (2 2%) 15 (1.7%) 
Reiter et al. 1978 1403 103 (7.3%) 33 (2 4%) 21 (1.5%) 
Ligoury & Loriga 1978 144 21 (14.6%) 2 (1 4%) 1 (0.7%) 
Montori et al. 1979 194 13 (6.7%) 1 (0 5%) 1 (0.5%) 
Nakaiima et al. 1979 485* 37 (7.6%) 6 (1 2%) 2 (0.4%) 
Cotton 1980 129 10 (7.8%) 6 (2 3%) 1 (0.8%) 
Geenen et al. 1981 1250* 109 (8.7%) 23 (1 8%) 15 (1.2%) 
Siegel 1981 258 14 (5.4%) 2 (0 8%) 2 (0.8%) 
Viceconte et al. 1981 255 18 (7.1%) 1 (0 4%) 2 (0.8%) 
Cotton & Vallon 1981 590 58 (9.8%) 11 (1 9%) 7 (1.2%) 
Mee et al. 1981 69 9 (13.0%) 3 (4 3%) 0 (0%) 
Cotton & Vallon 1982 70 6 (8.6%) 2 (2 9%) 0 (0%) 
Kawai et al. 1983 496* 17 (3.4%) 6 (1 2%) 2 (0.4%) 
Roberts-Thompson 1984 300 14 (4.7%) 3 (1 0%) 0 (0%) 
Escourrou et al. 1984 407 27 (6.6%) 7 (1 7%) 6 (1.5%) 
Neoptolemos et al. 1984 98 13 (13.3%) — 1 (1.0%) 
Leese et al. 1985 394* 41 (10.4%) 15 (3 8%) 3 (0.8%) 
Davidson et al. 1988 106* 21 (19.8%) 6 (5 7%) 5 (4.7%) 
Rosseland & Solhauq 1988 75 10 (13.3%) 2 (2 6%) 1 (1.3%) 
Abbreviations: N = Total number of papillotomies performed (or 
attempted, see below) in the series; Comp = Number and percentage of 
early complications following the procedure; Surg = Number and 
percentage of patients requiring emergency surgery for treatment of 
immediate complications; Death = Number (and percentage) of deaths 
directly related to papillotomy; — = Data not given. 
* These studies report morbidity and mortality rates of all attempted 
papillotomies (as opposed to all successful procedures). If 
complications and deaths occurred only among patients who underwent 
successful papillotomy, then the percentages reported in these series 
are slightly lower than the comparable rates given in the other studies. 
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Endoscopic papillotomy is contraindicated in certain 
situations, such as the presence of: 1) uncorrectable 
coagulation disorders, 2) long distal common duct stric¬ 
tures, and 3) abnormalities of the proximal bile ducts 
unapproachable endoscopically. 2 7 * 3 0 * 3 2 • 37•41~43 • 60 Some 
endoscopists consider large stones (greater than 20-25 mm in 
diameter) and juxta-ampullary diverticula relative contra¬ 
indications, since these conditions increase the difficulty 
of stone extraction and cannulation, respec- 
tively.30■ 3 2 * 3 6 • 37 ■ 4 1 ■ 43 • 47 • 60 Some endoscopists have 
successfully used crushing and lithotripter baskets to 
fragment and remove large stones.31 * 36■56 ■ 60"62 Acute 
pancreatitis has been considered a contraindication to 
papillotomy by some authors,3° • 32 • 37•43 but others have used 
this technique effectively to treat acute gallstone pancrea¬ 
titis.41 ■ 47'49 
Papillotomy in Patients with an Intact Gallbladder: 
Initially, endoscopic papillotomy was used primarily to 
treat patients with retained or recurrent common duct stones 
after cholecystectomy.3 1 • 43 • 63 In this setting, endoscopic 
therapy offered a clear advantage over re-operation. The use 
of endoscopic treatment was questioned, however, in patients 
with an intact gallbladder. For years surgeons had cautioned 
that permanent destruction of the sphincter of Oddi could 
lead to later complications if the gallbladder was left in 
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place. Frequent development of acute and chronic inflamma¬ 
tory changes in the gallbladder wall, often accompanied by 
stones and uniformly associated with bacterial infection, 
has been described after surgical sphincterotomy and chole- 
dochoenterostomy in both dogs64'67 and humans.68 Investi¬ 
gators attributed this outcome to the ascent of pathogens 
from the duodenum, with the gallbladder acting as a 
reservoir of infection. Thus, surgeons have long advocated 
cholecystectomy when performing biliary bypass surgery or 
sphincter ablation.12,68"70 According to Jones,12 "the gall¬ 
bladder cannot fill and function normally in the absence of 
the distal sphincters, and if it is left behind, stasis and 
infection may develop." As a result, endoscopic papillotomy 
without cholecystectomy was initially reserved for patients 
considered poor surgical candidates, due to age and/or 
coexisting illness.27,32"34,37'43,55 In such cases the 
immediate advantages of endoscopy over surgery outweighed 
the potential long-term risks of leaving the gallbladder in 
situ in the presence of a nonfunctional sphincter of Oddi. 
With further experience, however, endoscopic papil¬ 
lotomy has been employed increasingly in patients with a 
gallbladder in situ. Upon recovery, many such persons are 
discharged with their gallbladder in place. The percentage 
of patients left with an in situ gallbladder after papil¬ 
lotomy varies widely among different centers, ranging from 
6-61%2 7 - 3 O . 3 2 . 3 4 , 3 5 . 3 7 . 3 9 - 4 2 , 4 4 . 4 5 . 4 7 , 5 0 - 5 2 . 5 7 . 6 3 . 7 1 - 7 3 ( ggg 
Table 4). Management of these individuals has been a subject 
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Table 4: Percentage of papillotomies performed on patients with an 
intact gallbladder. 
Safrany 1977 Munster 185 39 
o 
21.1% 
Safrany 1978 15 International 3070 887 28.9% 
Siefert 1978 9 German 743 171 23.0% 
Reiter 1978 9 German 1403* -- 20.5% 
Ligoury & Loriga 1978 Paris 145* * 73 50.3% 
Montori et al. 1979 8 Italian 194* 19 9.8% 
Nakajima et al 1979 25 Japanese 430 154 35.8% 
Cotton 1980 London 129 15 11.6% 
Geenen et al. 1981 21 U.S. 1106 93 8.4% 
Siegel 1981 New York 230 15 6.5% 
Viceconte et al. 1981 Rome 254* 41 16.1% 
Cotton & Vallon 1981 14 British 679* * 70 10.3% 
Mee et al. 1981 London 71* * 15 21.1% 
Cremer et al. 1981 Brussels 809* 496 61.3% 
Cotton & Vallon 1982 London 310 71 22.9% 
Roberts-Thompson 1984 Melbourne 227 51 22.5% 
Escourrou et al. 1984 Toulouse 407 234 57.5% 
Leese et al. 1985 Leicester 319 — 58% 
Kullman et al. 1985 Sweden 202* 101 50.0% 
Tulassay & Papp 1985 Budapest 525* 131 25.0% 
Thompson 1986 Bristol 64 23 35.9% 
Jacobsen & Matzen 1987 Copenhagen 96 44 45.8% 
Siegel et al. 1988 Wilhelmshaven/N.Y. 4177* 1272 30.5% 
Abbreviations: # Pap = Number of successful papillotomies performed (or 
attempted, as noted) for choledocholithiasis (does not include 
procedures performed for other indications, except when noted, see 
below); # GB = Number of papillotomies performed (or attempted) on 
patients with an intact gallbladder; % GB = Percentage of patients 
undergoing papillotomy with a gallbladder in place. 
* Includes papillotomies performed for choledocholithiasis as well as 
other indications. 
Statistics refer to the number of papillotomies attempted; data on the 
number of procedures successfully performed in patients with a 
gallbladder is not given. 
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of debate. Initially, the potential long-term risk of chole¬ 
cystitis led some experts to recommend elective cholecystec¬ 
tomy after papillotomy.74"76 Rosch et al.75 in 1981 
professed that "Late complications must be expected in 
patients with gallbladder in situ; cholecystectomy is there¬ 
fore advisable in papillotomized patients after improvement 
of their general condition." However, many clinicians now 
consider pre-emptive surgery in asymptomatic individuals 
unwarranted.31 ■ 5 2 * 5 3 ■ 55 • 63 • 77" 79 Riemann et al.77 in 1983 
stated that "The idea . . . that, following endoscopic 
papillotomy, the gallbladder should ... be extirpated, 
since the loss of function of the gallbladder after sphinc¬ 
terotomy, possibly in conjunction with the ascent of 
bacteria, would promote cholecystitis, can now be dropped." 
However, the authors still cautioned that sphincter ablation 
may lead to very long-term sequelae in young persons. 
Follow-up data on patients with an intact gallbladder 
after papillotomy are quite variable. Table 5 shows the 
results of several series on patients undergoing papillotomy 
with a gallbladder in place. The incidence of acute chole¬ 
cystitis in this population varies from 0-16.7%, and the 
rate of subsequent cholecystectomy ranges from 
0-26.7%.38 * 51"55 • 59 ■ 63 • 72' 83 Comparison of these statistics 
is difficult, however, because of non-standard methods of 
reporting. Many studies report the rate of cholecystectomy 
after papillotomy, but not all investigators distinguish 
between prophylactic elective operation in asymptomatic 
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Table 5: Long-term follow-up of patients with an intact gallbladder 
after endoscopic papillotomy. 
F/U Period # (Z) Cbolecystectony: Chole- 
Investiqator(s) Date Ranqe (Mean) N Elective Symptoms Total cystitis 
Hagenmiiller et al. 1979 l-4y 68 - 7 (10.3%) 7 (10.3%) 6 (8.8%) 
Cotton 1980 3-36m 8 * 1 (12.5%) - 2 (25%) 
Rosch et al. 1981 2-7y 101 - - 23 (22.8%) - 
Cremer et al. 1981 - 496 4% 4% - 6% 
Safrany et al. 1982 2-8y 352 76 (21.6%) 18 (5.1%) 94 (26.7%) 40 (11.4%) 
Cotton & Vallon 1982 4m-5y (19m) 70 11 (15.8%) 5 (7.1%) 16 (22.9%) 2 (2.9%) 
Riemann et al. 1983 2-9y 206 24 (11.7%) 15 (7.3%) 39 (18.9%) - 
Escourrou et al. 1984 6-66m (22m) 130 - 7 (5.4%) - 8 (6.2%) 
Neoptolemos et al. 1984 4-50m (17m) 38 - 1 (2.6%) 1 (2.6%) 1 (2.6%) 
Solhaug et al. 1984 2w-60m (28m) 22 3 (13.6%) - - - 
Winstanley et al. 1985 18-76m 22 - - 0 (0%) - 
Sieqel 1985 up to 7y 212 - - - - 
Tulassay & Papp 1985 up to ly 131 - - - 10 (7.6%) 
Martin & Tweedle 1987 12-44m (24m) 70 5 (7.1%) 4 (5.7%) 9 (12.9%) - 
Tanaka et al. 1987 - 122 ** 3 (2.5%) 8 (6.6%) 5 (4.1%) 
Jacobsen & Matzen 1987 2-81m (4.1y) 44 - 1 (2.3%) - 0 (0%) 
Worthley & Toouli 1988 2-42m 20 - 3 (15%) 8 (40%) 5 (25.0%) 
Davidson et al. 1988 l-8y (30m) 85 1 (1.2%) 6 (7.1%) 7 (8.2%) 3 (3.5%) 
Siegel et al. 1988 *** 1272 - 133 (10.5%) - 111*** 
Miller et al. 1988 - (28m) 34 - 7 (20.6%) 7 (20.6%) - 
Rosseland & Solhauq 1988 5-8y 66 2 (3.0%) 11 (16.7%) 13 (19.7%) 11 (16.7%) 
Abbreviations: F/U Period = period of follow-up (range and mean); N = 
Total number of patients; # (%) Cholecystectomy = Number and percentage 
of patients undergoing subsequent cholecystectomy; Elective = patients 
undergoing elective operation, mostly for prophylactic excision of the 
gallbladder, but some studies may include patients undergoing "elective" 
(i.e., non-emergent) surgery for symptomatic biliary illness; Symptoms = 
patients operated on for biliary symptoms (including, but not limited 
to, acute cholecystitis); Cholecystitis = number and percentage of 
patients developing cholecystitis after papillotomy (not all studies 
specify acute vs. chronic cholecystitis); - = Data not given. 
* A total of 12 patients with an intact gallbladder underwent 
papillotomy, early elective prophylactic cholecystectomy was performed 
in 4 (33%), leaving 8 persons available for long-term follow-up. 
This study was based on a total of 162 patients, 40 of whom (24.7%) 
underwent prophylactic cholecystectomy electively shortly after 
papillotomy (all of them had documented gallstones). 
* * * Of these 111 patients, 109 (8.6% of 1272) developed acute 
cholecystitis within 10 days of papillotomy. Two of 337 patients (0.6%) 




persons and surgery for cholecystitis or biliary symptoms. 
Also, a significant percentage of patients require cholecys¬ 
tectomy early (within one month) after papillotomy. Some 
studies include these cases in follow-up statistics, while 
other exclude these data as not representative of "long¬ 
term" outcome. Since endoscopic papillotomy has only been in 
use for fifteen years, follow-up information is limited. 
Many investigators believe that definitive conclusions 
(especially regarding young patients with a relatively long 
life expectancy after papillotomy) must await longer study 
periods. 
Predicting Gallbladder Disease After Papillotomy: 
Some investigators have attempted to define predictive 
factors for the development of cholecystitis after endo¬ 
scopic papillotomy. Cotton56 in 1984 first proposed that an 
obstructed cystic duct noted at the time of papillotomy may 
lead to eventual gallbladder complications. Solhaug et al.B0 
reported follow-up data on 22 patients with an intact gall¬ 
bladder at the time of papillotomy, twelve of whom demon¬ 
strated a lack of gallbladder filling on ERCP. After a two 
week to 60 month (median 28 month) follow-up period, four 
(33%) of these twelve patients required cholecystectomy for 
biliary symptoms. After six months to nine years of follow¬ 
up, Tanaka et ai.82 in 1987 noted the occurrence of acute 
cholecystitis in two (33%) of six patients with a previously 
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non-visualized gallbladder, and in three (12%) of 25 persons 
with documented gallstones. No instances of acute cholecys¬ 
titis were seen among 91 patients with stone-free gall¬ 
bladders at ERCP. The authors thus stated that "cholecystec¬ 
tomy should be advocated ... in patients with gallstones 
or nonvisualization of the gallbladder after endoscopic 
sphincterotomy due to the high incidence of acute cholecys¬ 
titis in this subgroup." Worthley and Toouli83 in 1988 noted 
a lack of gallbladder opacification on ERCP in eight of 
twenty patients. Six (75%) of these eight required cholecys¬ 
tectomy for acute cholecystitis within three to 28 months 
(median seven months), and three died postoperatively. Two 
(16.7%) of the twelve individuals whose gallbladders filled 
required cholecystectomy shortly after papillotomy, and the 
other ten persons remained symptom-free after a 2-42 month 
(median nine month) follow-up period. The authors concluded 
that "Should the gallbladder fail to opacify despite free 
cannulation of the common bile duct, dense opacification of 
the extrahepatic biliary tree and filling of the tertiary 
intrahepatic bile ducts, then cholecystectomy is recommended 
to avoid future gallbladder complications." 
However, not all studies agree on this point. Martin 
and Tweedle81 in 1987 reported on 70 patients with gall¬ 
bladders whose common ducts were cleared of stones at papil¬ 
lotomy. Of four patients who required cholecystectomy for 
symptoms within six months, three (75%) demonstrated gall¬ 
bladder visualization on ERCP. The authors also commented on 
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one patient who subsequently required surgery despite having 
no evidence of gallstones (either before or after cholecys¬ 
tectomy) , and thus stated that "We have not been able to 
correlate any clinical, endoscopic or radiological variable 
with the need for surgery." 
There is also disagreement as to whether a lack of 
gallbladder opacification on ERCP is truly indicative of 
cystic duct obstruction, as Cotton has claimed.84 Rohrmann 
et al.BB in 1979 followed 63 patients with this finding. At 
surgery or autopsy, 35 (55.6%) had a distal common bile duct 
obstruction (with no abnormality of the cystic duct or gall¬ 
bladder), nineteen (30.2%) had obstructing lesions of the 
cystic duct or gallbladder (with normal common ducts), eight 
(12.7%) had biliary obstruction at the junction of the 
cystic and common hepatic ducts, and one patient (1.6%) had 
a normal biliary tree. This study demonstrates that non¬ 
filling of the gallbladder on ERCP does not necessarily 
imply cystic duct obstruction, but may be related to 
sludging and stasis of bile caused by a distal common duct 
lesion. Since papillotomy is nearly always performed in the 
setting of common duct obstruction, it follows that ERCP 
observations cannot be used to determine cystic duct 
patency. Of course, this conclusion does not invalidate the 
value of this particular finding for predicting future gall¬ 
bladder complications. Regardless of the meaning of an 
unfilled gallbladder on ERCP, the reliability of this sign 
as a predictor for subsequent disease depends upon 
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statistical correlation with long-term outcomes. Studies 
with larger series and longer follow-up periods are 
necessary before definite conclusions can be drawn. 
The most important risk factor for the development of 
acute cholecystitis is the presence of stones in the gall¬ 
bladder. Although few studies have reported the incidence of 
gallbladder calculi in patients undergoing papillotomy, 
gallstones are likely present in the majority of such 
persons. Tanaka et al.B2 noted gallstones in 65 (40%) of 162 
papillotomy patients with an intact gallbladder. However, 
one European72 study quoted a lack of cholelithiasis in 46 
(9%) 496 cases, and a large European and American study63 
found 1208 (95%) of 1272 such patients to have demonstrable 
gallbladder stones at the time of papillotomy. This varia¬ 
bility may be related to the prevalence of gallstones in 
Asian versus Western populations. After papillotomy, 
however, the pathophysiological significance of gallstones 
may be diminished, since patients often pass gallbladder 
stones spontaneously following destruction of the sphincter 
of oddi.51 • 55 • 56 ■ 63 ■ 8°* 82 A recent study corroborated this 
observation by demonstrating that papillotomy facilitated 
the passage of glass beads placed into canine gall¬ 
bladders.86 Not surprisingly, small beads passed with much 
greater frequency than large ones. Even after sphincter 
ablation, any single stone of sufficient size can lodge in 
the cystic duct and lead to cholecystitis. 
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It is also possible that individuals may continue to 
form gallstones after papillotomy. Data on this subject is 
contradictory. Cohn et al.B7 noted increased lithogenicity 
(for cholesterol stones) of gallbladder bile following 
sphincterotomy in dogs. However, Hutton et al.BB found a 
decreased incidence of gallstones in prairie dogs after 
papillotomy. It is not clear what changes take place in 
human bile after sphincter ablation. Matsumoto and 
Tanaka82,89 reported the subsequent formation of calcium 
bilirubinate gallstones (demonstrated by ERCP and proven by 
cholecystectomy) in two patients who had no stones evident 
radiographically at the time of papillotomy. Since pigment 
calcium gallstones have been associated with infected bile 
(one study noted positive bacterial cultures from gall¬ 
bladder bile in 80% of cases of calcium bilirubinate gall¬ 
stones90), the authors suggested that ascending infection of 
the biliary tract could have contributed to stone formation. 
Incidentally, one could argue that in isolated cases, "new" 
gallstones might represent stones that were missed on 
initial ERCP. However, that is unlikely in these instances, 
since calcified pigment stones are usually apparent on plain 
radiographs. At any rate, numerous follow-up studies have 
found that acute cholecystitis does occur after papillo¬ 
tomy.5 1 - 5 5 . 5 9 . 6 3 , 7 1 - 7 2 . 7 4 , 7 6 . 7 7 , 7 9 . 8 2 . 8 3 
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Radiologic Diagnosis of Acute Cholecystitis: 
Characteristic clinical and laboratory findings of 
acute cholecystitis include: 1) a history of right upper 
quadrant pain (often precipitated by a fatty meal), 
anorexia, nausea, vomiting, and fever; 2) abdominal tender¬ 
ness, inspiratory arrest on deep palpation over the gall¬ 
bladder (Murphy's sign), a palpable gallbladder, and fever 
on physical examination; and 3) an elevated leukocyte count. 
Although classic, such signs and symptoms are by no means 
specific for this disease. The differential diagnosis of 
right upper quadrant abdominal pain includes such conditions 
as appendicitis, pancreatitis, perforated ulcer, bowel 
ischemia, diverticulitis, mesenteric adenitis, acute hepatic 
congestion, hepatic mass lesions, gonococcal perihepatitis, 
renal colic, pyelonephritis, ovarian torsion, ruptured 
ectopic pregnancy, pneumonitis, and acute myocardial infarc¬ 
tion.9- 91,92 Appropriate radiologic procedures are necessary 
to confirm the presence of gallbladder disease before 
instituting surgical therapy. Currently employed diagnostic 
imaging studies for detecting acute cholecystitis include 
ultrasonography and cholescintigraphy. Older biliary imaging 
modalities such as oral cholecystography and intravenous 
cholangiography are now rarely used in this clinical 
setting. 
Sonographic diagnosis of cholelithiasis was first 
reported in 1963.93 Ultrasonography has since become a 
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valuable tool in biliary tract imaging. Sonography is 
extremely sensitive for detecting stones in the gallbladder. 
However, this observation does not constitute proof of acute 
cholecystitis, since many people (an estimated 15-20 million 
Americans) have "silent" gallstones.10,92 Biliary sono- 
graphers have therefore defined a spectrum of findings 
associated with an abnormal gallbladder. Major sonographic 
criteria indicative of gallbladder disease include: 1) the 
presence of gallstones, or 2) a non-visualized gallbladder 
(implying a shrunken and diseased organ, usually seen in 
chronic cholecystitis). Various ancillary sonographic 
findings have been associated with acute gallbladder 
illness. These so-called minor criteria for acute cholecys¬ 
titis include: 1) intramural sonolucency (representing edema 
of the gallbladder wall), 2) pericholecystic inflammation or 
abscess, 3) tenderness over the gallbladder elicited by the 
transducer (sonographic Murphy's sign), 4) gas in the gall¬ 
bladder wall or lumen, 5) thickening of the gallbladder 
wall, 6) gallbladder distension, and 7) sludge.92'94 In most 
studies, ultrasonography utilizing only major criteria is 
81-86% sensitive in confirming a clinical suspicion of acute 
cholecystitis, and has a specificity of 94-98%. Adding minor 
criteria increases the sensitivity to 90-98%, but lowers the 
specificity to 70-76%.92,94 The limitation of ultrasound in 
diagnosing acute cholecystitis is that this imaging tech¬ 
nique provides only anatomic information, and cannot assess 
the functional patency of the cystic duct. 
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Cholescintigraphy using 99mTc-labelled tracers was 
introduced in the mid-1970's.95 • 96 This nuclear imaging 
modality involves intravenous injection of a radioactive 
tracer selectively taken up by hepatocytes and excreted into 
the bile. Currently used radiopharmaceuticals include 
several chemical derivatives of iminodiacetic acid (IDA). 
These agents are organic anions chelated to a 99mTc atom, 
which cross hepatocyte membranes by a carrier-mediated 
transport mechanism, similar to bilirubin uptake. The liver 
removes 80-85% of the administered dose of tracer from the 
bloodstream (the remainder undergoes renal excretion), and 
IDA derivatives are secreted unmodified into bile canali- 
culi.92•9 5 * 9 7 * 9 8 Following injection of radioisotope, serial 
images obtained with a gamma camera depict the flow of 
labelled bile through the hepatobiliary system. Figure 5 is 
a schematic diagram depicting the hepatobiliary transit of 
99mTc-IDA agents. In a normal study, liver uptake occurs 
rapidly, followed by appearance of tracer in the bile ducts, 
gallbladder, and intestine within one hour. The classic 
scintigraphic finding in acute cholecystitis is a lack of 
visualization of the gallbladder, in the presence of normal 
visualization of the bile ducts and bowel, indicative of a 
blocked cystic duct.92•94•97"99 Cholescintigraphy is 
performed after a fast of at least two hours (preferably 
overnight), in order to prevent false positive scans due to 
gallbladder contraction stimulated by a recent meal. 
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Figure 5: Schematic diagram of the flow of 99mTc-IDA 
derivatives through the hepatobiliary system. Tracer is 
loosely bound to albumin in the bloodstream, and enters 
hepatocytes by a carrier-mediated transport mechanism. 
99mTc-IDA compounds are secreted unconjugated into bile 
canaliculi. (Modified from Krishnamurthy, 1988.9®) 
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The reported sensitivity of cholescintigraphy for 
detecting acute cholecystitis ranges from 85-100%, with most 
studies reporting values of 95-98%. Specificity varies from 
70-100% in clinical series, with typically reported values 
around 90-97%.92 ■ 94 • 1 °°'118 These data are summarized in 
Table 6. False negative tests can occur in cases of acute 
acalculous cholecystitis. Delayed gallbladder visualization 
(between one and four hours) also occurs rarely in acute 
cholecystitis. This finding is usually associated with 
chronic cholecystitis. Nonvisualization of the gallbladder 
has been observed in the following conditions: 1) chronic 
cholecystitis, 2) pancreatitis, 3) severe intercurrent 
illness, 4) alcoholism, 5) prolonged fasting, 6) lack of 
adequate fasting, 7) hyperalimentation, 8) trauma, and 9) 
gallbladder neoplasms.92 • 94 • 97 • 99 In most series, however, 
false positive tests for acute cholecystitis are rare. 
Numerous studies have compared the relative utility of 
ultrasonography and cholescintigraphy in detecting gall¬ 
bladder disease>i 0 5 , 1 0 6 . 1 0 9 - 1 1 1 , 1 1 3 , 1 1 4 , 1 1 6 - 1 2 0 These 
investigations are not fully comparable, due to: 1) 
differences in study design and patient selection 
(prospective vs. retrospective); 2) variability in imaging 
technique, such as equipment used (static vs. real time 
ultrasonography), sonographic criteria chosen for acute 
cholecystitis, the particular radiopharmaceutical used, and 
timing of scintigraphy (i.e., how long the test was carried 
out); and 3) different methods of follow-up, including means 
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Table 6: Results of 99mTc-IDA cholescintigraphy in diagnosing acute 
cholecystitis. 
Investiqator(s) Date Sensitivity Specificity 
Weissman et al. 1979 95% 100% 
Freitas et al. 1980 100% 90% 
Suarez et al. 1980 97.6% 75% 
Szlabick et al. 1980 100% 97.6% 
Freitas & Gulati 1980 97% 87% 
Zeman et al. 1981 98% 81% 
Worthen et al. 1981 95% 100% 
Weissman et al. 1981 95.2% 99.2% 
Hall et al. 1981 100% 70% 
Freitas et al. 1982 98.3% 90.2% 
Shuman et al. 1982 86% 73% 
Ralls et al. 1982 85.7% 83.9% 
Mauro et al. 1982 100% 94% 
Matolo et al. 1982 93% 100% 
Freitas et al. 1983 100%* 85.1%* 
95.3%* * 98.6%* * 
Samuels et al. 1983 97% 93% 
Cabellon et al. 1984 100% 96% 
Gill et al. 1985 100% 100% 
Fink-Bennett et al. 1985 97% — 
‘Using "strict" criteria for acute cholecystitis (pathologically 
demonstrated transmural acute inflammatory infiltrates), and gallbladder 
visualization time (within 1 hour). 
**Using "liberal" criteria for acute cholecystitis (any of the 
following: transmural acute inflammatory infiltrates, hemorrhagic 
necrosis of gallbladder wall or mucosa, complete cystic duct 
obstruction, or postcholecystectomy relief of pain/fever/leukocytosis); 
and gallbladder visualization time (within 4 hours). 
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of proving the final diagnosis (clinical vs. pathological), 
and the specific pathologic criteria used to define acute 
vs. chronic cholecystitis. Only two studies106,110 
recommended sonography as the initial diagnostic procedure 
of choice for suspected acute cholecystitis. Most 
investigators1 °5.109.111.113. 114,116-120 found scintigraphy 
more sensitive than sonography in detecting acute cholecys¬ 
titis, and thus recommended cholescintigraphy as the most 
appropriate initial test in this setting. Marton and 
Doubilet94 recently performed an extensive review of the 
literature and reached the same conclusion. They suggested 
using ultrasonography first for evaluating patients 
suspected of having chronic gallbladder disease, and chole¬ 
scintigraphy first in suspected cases of acute cholecystitis 
(defined as acute inflammation accompanied by cystic duct 
obstruction). Most experts agree that 99mTc-IDA cholescin¬ 
tigraphy represents the "gold standard" for the radiologic 
confirmation of clinically suspected acute cholecystitis. 
Cholescintigraphy in the Setting of Sphincter Ablation: 
Cholescintigraphy is an excellent diagnostic test for 
acute cholecystitis in patients with an intact biliary 
system. Its efficacy, however, has not been studied after 
endoscopic papillotomy in humans. In this setting, lack of 
resistance at the terminal common bile duct may allow bile 
to flow completely unimpeded into the duodenum, bypassing 
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the gallbladder entirely. It is therefore possible that the 
gallbladder may not visualize following sphincter ablation, 
even if the cystic duct is patent. A false positive test for 
acute cholecystitis is potentially dangerous, since such 
diagnostic data could form the basis of a decision to 
operate on an acutely ill patient. Studies have found that 
patients with acute cholecystitis benefit from early chole¬ 
cystectomy . 1 2 1 " 1 24 Many surgeons thus favor rapid diagnosis 
and operative treatment of this disease. The majority of 
persons with an intact gallbladder treated with papillotomy 
are elderly, and therefore subject to great risk from 
emergency surgery. This study was undertaken to assess 
baseline cholescintigraphic findings in individuals with an 
in situ gallbladder after endoscopic papillotomy. By deter¬ 
mining whether or not the gallbladder visualizes in such 
persons when they are clinically asymptomatic, one can 
ascertain the reliability of this diagnostic modality for 
detecting acute cholecystitis in patients who have undergone 
papillotomy. Since cholescintigraphy measures gallbladder 
filling, knowledge of the mechanism of this process will 
allow a more complete understanding of the utility and 
limitations of this imaging method in different populations. 
Possible Mechanisms of Gallbladder Filling: 
The earliest theory of gallbladder function ascribed 
control of the filling process to the sphincter of Oddi. 

37 
Between meals the majority of secreted bile enters the gall¬ 
bladder for storage. It was thus thought that tonic contrac¬ 
tion of the sphincter during fasting diverted all bile into 
the gallbladder. Observations of a biliary sphincter date 
back to Vesalius, who noted a membrane at the distal orifice 
of the common bile duct, which he believed prevented reflux 
of duodenal contents into the biliary tree. Glisson proposed 
the existence of a choledochal sphincter in 1681. In 1879 
the zoologist Gage provided the first anatomic description 
of this muscle in the cat. Oddi subsequently demonstrated 
the presence of a common duct sphincter in several animal 
species in 1887, and in 1898 Hendrickson described this 
structure in man.4, 125 From these early observations, 
medical scientists concluded that this terminal sphincter 
was the means of regulating bile flow from the gallbladder 
to the intestine. It seems perfectly logical that, when the 
sphincter closes, the rising pressure in the common duct 
would force bile into the gallbladder. In this model the 
gallbladder acts as a capacitance organ, a low pressure 
reservoir which expands to accommodate the continuous flow 
of bile into a closed system. Gallbladder filling is 
therefore an entirely passive process. This mechanism is 
described in numerous medical texts.3 * 8■ 126 " 13 1 Alterna¬ 
tively, some researchers have proposed that contraction of 
the duodenal musculature (either instead of, or in addition 
to, sphincter activity) may be responsible for generating 




Numerous clinical and laboratory studies, however, have 
suggested that filling of the gallbladder may be mediated by 
a more complex network of physiologic interactions, under 
autonomic and hormonal control. Utilizing techniques such as 
gallbladder and sphincter of Oddi manometry,136"138 bile 
flow measurement,139-141 electromyography,136•140"143 
cineradiography,142*144 and biliary scintigraphy,145"147 
researchers have found evidence of periodic gallbladder and 
sphincter motor activity in the interdigestive state. These 
findings have been reported in humans s 1 3 7 - 1 3 9 • 142, 144-146 
dogs,136-140 prairie dogs,146'147 and opossums.143 During 
fasting, the gallbladder does not fill at a constant rate; 
it is subject to fluctuations of bile flow and often under¬ 
goes partial contraction. These variations in biliary 
motility are regular and occur in synchrony with the intes¬ 
tinal migrating myoelectric complex (MMC).136 • 140"142 The 
MMC is a rhythmic pattern of myoelectric, motor, and 
secretory activity which propogates in a caudad direction 
along the entire small bowel from antrum to terminal 
ileum.148 Thus, rather than relying exclusively upon biliary 
pressure, contractions and relaxations of the gallbladder 
wall musculature could act to forcibly pump bile into the 
sac. The spiral valves of the cystic duct may also play a 
role. In this model the gallbladder becomes an active 
participant in the filling process, functioning as a 
bellows. Experimental evidence has been found which suggests 
both active and passive modes of gallbladder filling. 
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Experimental Studies of Gallbladder Filling: 
Radiographic imaging of the gallbladder by intravenous 
injection of tetrabromophenolphthalein was first described 
in 1924.149 Copher150 in 1925 reported that gallbladder 
opacification required an intact choledochal sphincter. 
"Experimentally and clinically, the retention of the bile in 
the biliary tract by the sphincter of the common duct is 
necessary to secure good shadows of the gallbladder." Cannu- 
lation of the common bile duct in dogs resulted in a lack of 
visualization of the gallbladder by intravenous cholecysto¬ 
graphy. Copher explained this finding by proposing that 
"canalization of the common duct permitted free outflow of 
bile from the liver," thereby implying that some distal 
resistance to bile flow was necessary for the gallbladder to 
fill. In 1926 Copher et al.133 subjected dogs to cholecys¬ 
tectomy and anastomosed a thin rubber bag to the cystic 
duct. Subsequent intravenous cholecystography demonstrated 
opacification of this artificial gallbladder. Since rubber 
bags obviously possess no intrinsic motor activity, filling 
must have occurred passively, as a result of biliary 
pressure. Unfortunately, Copher did not repeat this experi¬ 
ment in sphincterotomized animals, which would have demon¬ 
strated whether or not the sphincter of Oddi was important 
in generating the necessary pressure. 
Burget151 in 1925 measured changes in flow resistance 
in the common bile duct in dogs in response to 
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administration of pilocarpine, physostigmine, atropine, and 
epinephrine. Pilocarpine and physostigmine increased biliary 
pressure, while atropine and epinephrine caused a fall in 
biliary pressure. Burget attributed these effects to the 
pharmacologically induced changes in intestinal motor tone. 
In a subsequent experiment,134 he performed the same 
measurements after transecting the common duct immediately 
proximal to the sphincter of Oddi and then directing the 
duct into the duodenum through a surgically created orifice. 
This effectively eliminated the sphincter, while preserving 
the structure of the duodenal musculature surrounding the 
distal common bile duct. Burget found similar effects on 
biliary pressure following drug adminstration in this second 
set of dogs. He thus concluded that "The sphincter of Oddi 
is probably not at all concerned in the regulation of the 
flow of bile, at least not in animals where the duct enters 
the duodenal musculature obliquely." 
Like Copher, Whitaker132 in 1926 noted a lack of gall¬ 
bladder visualization in dogs following intravenous injec¬ 
tion of tetraiodophenolphthalein after cannulation of the 
common bile duct. Upon surgical ablation of the sphincter, 
however, he obtained normal cholecystograms in three dogs. 
Patency of the choledochal orifice was confirmed at autopsy 
in one dog. Whitaker thus stated that "This seems to show 
that an actual sphincteric action at the papilla is not 
necessary to the filling of the gallbladder, but that other 
factors, such as pressure of the intestinal musculature 
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where the duct passes through, possibly serve this 
function." Interestingly, no gallbladder filling was noted 
after cutting the sphincter in five cats. The author made no 
attempt to explain these contradictory findings, which may 
have been due to species variation. 
In 1952, Jones and Smith70 performed follow-up imaging 
studies in three patients with intact gallbladders after 
transduodenal sphincteroplasty (for treatment of recurrent 
pancreatitis). Before surgery, all three individuals had 
normally functioning gallbladders by cholecystography. At 
operation, all three gallbladders appeared grossly normal, 
with no palpable stones. The common bile duct was explored 
and found to be free of stones in two patients. Cholecysto¬ 
graphy performed at two, three and a half, and four months 
postoperatively revealed non-opacifying gallbladders in all 
three individuals. In one person reflux of barium into the 
common duct was seen on upper GI examination (confirmation 
of sphincter incompetence). Data from this small series 
suggest that either: 1) the sphincter of Oddi plays a 
prominent role in gallbladder filling in humans, or 2) 
sphincter ablation predisposes to gallbladder disease. Both 
conclusions may be true and causally related. 
In 1960 Lempke135 performed oral cholecystography in 
eight patients who had undergone either surgical sphincter¬ 
otomy or sphincter resection with biliary-enteric 
anastomosis. In contrast to Jones' and Smith's observations, 
opacification of the gallbladder occurred in six of eight 
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individuals between two weeks and 21 months after surgery. 
In the remaining two patients the gallbladder visualized, 
but demonstrated decreased concentration of contrast as 
compared to preoperative studies. In three patients (two of 
whom had normal cholecystograms) postoperative sphincter 
incompetence was suggested by the presence of air in the 
bile ducts on roentgenography (one case) or reflux of barium 
into the common duct on upper GI studies (two cases). To 
explain these findings, Lempke proposed that gallbladder 
filling could have resulted from the resistance to bile flow 
provided by 1) the duodenal musculature, 2) partial 
obstruction due to biliary sediment (noted in one case), 3) 
extrinsic pressure from an indurated pancreatic head (noted 
in one case), or 4) restenosis of the papillary orifice. 
However, he ultimately concluded that "these observations . 
. . cast some doubt on the significance of the sphincter of 
Oddi in gallbladder function in man." 
Tansy et al.152 in 1974 performed a series of experi¬ 
ments to ascertain the role of the intramural common bile 
duct in gallbladder filling in dogs. They measured gall¬ 
bladder filling directly by timed aspiration of bile through 
a catheter inserted into the fundus. For comparison, cannu- 
lation of a hepatic duct allowed determination of the rate 
of hepatic secretion of bile. The amount of bile flowing 
into the gallbladder dropped dramatically after cannulation 
of the entire length of the intramural common duct, and rose 
sharply once the catheter was withdrawn. Gallbladder filling 
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also dropped precipitously after transection of the common 
duct, and rose steeply when the duct was clamped. However, 
surgical exteriorization of the entire intramural common 
duct and removal of all surrounding muscle tissue did not 
affect the rate of filling. Subsequent histologic examina¬ 
tion of the denuded ducts confirmed that all muscular tissue 
had been removed. In a final experiment, the exteriorized 
common duct was transected in stages (2 mm at a time, 
beginning at the papilla), and gallbladder filling was 
measured after each of five successive cuts. After the 
initial 2 mm incision, the filling rate declined steadily as 
the intramural common bile duct was progressively elimin¬ 
ated. In all studies the rate of hepatic bile secretion 
remained constant. Based on these findings, the investi¬ 
gators concluded that gallbladder filling was dependent upon 
the occlusive ability of a structurally intact terminal 
common bile duct. However, since removal of all duodenal and 
sphincteric muscle tissue from an intact common duct did not 
reduce filling. Tansy et al. proposed that the occluding 
mechanism of the distal common duct was mediated by the 
vascular dynamics of the ductal epithelium, and not by 
action of the sphincter nor the duodenal musculature. 
Cohn et al.87 in 1979 performed transduodenal 
sphincteroplasty on six dogs, and studied them with chole- 
cystokinin-cholecystography and bile analysis at five and 
ten weeks postoperatively. Intravenous cholangiography 
revealed gallbladder opacification on ten of twelve 
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occasions. One dog had no gallbladder visualization at five 
weeks, and another showed no filling at ten weeks. Contrac¬ 
tility in response to CCK administration remained intact 
after sphincter ablation, although resting gallbladder 
volume was noted to be reduced, with mean values of 35.7 ml 
preoperatively, 28.1 ml at five weeks, and 18.8 ml at ten 
weeks. Alterations were also found in the composition of 
gallbladder bile. Cholesterol concentration did not change 
significantly, but diminished concentrations of both 
lecithin and bile acids resulted in a net increase in bile 
lithogenicity. Additionally, cultures of gallbladder bile 
revealed postoperative bacterial growth in all animals, as 
opposed to the finding of uniformly sterile bile before 
sphincteroplasty. Incompetence of the sphincter of Oddi was 
confirmed radiographically by the presence of duodenal- 
biliary reflux of contrast in all dogs, as well as the 
consistent finding of air in the common duct and gall¬ 
bladder. The investigators concluded that gallbladder 
filling and contractility remained normal after sphinctero¬ 
plasty, but that the resultant diminished concentrating 
ability, increased bile lithogenicity, and bacterial 
contamination represented a significant risk for gallbladder 
pathology. 
In 1983 Rosseland and Kolmannskog153 performed papillo¬ 
tomies on seven rabbits (using a standard papillotome and 
accessing the papilla through a duodenal incision), and 
analyzed gallbladder function with intravenous cholangio- 
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graphy after a three month follow-up period. Six control 
animals underwent duodenotomy and common duct cannulation, 
but no papillotomy was done. All thirteen animals showed 
normal gallbladder visualization preoperatively. Gallbladder 
filling did not occur after papillotomy in six of seven test 
animals, as compared to normal postoperative filling in all 
six control rabbits. Six months after papillotomy, radio- 
graphic contrast was instilled into a duodenal catheter. 
Free reflux of contrast material from the duodenum into the 
bile ducts occurred in six of seven test animals, confirming 
incompetence of the sphincter, whereas no reflux was evident 
in the six control rabbits. The results of this study 
clearly imply the importance of the sphincter of Oddi in 
gallbladder filling, at least in rabbits. 
In 1984 Van der Linden and Kempi154 studied a group of 
thirty normal subjects using computer-assisted 99mTc-HIDA 
cholescintigraphy. Quantitative analysis of isotope activity 
in specific regions of interest (ROI) yielded the following 
findings: 1) Visualization of the gallbladder tended to 
occur prior to that of the distal common bile duct. 2) The 
mean time after isotope injection at which gallbladder 
visualization became apparent was nearly identical in 
subjects with and without passage of activity into the 
duodenum. 3) Initial gallbladder filling occurred rapidly, 
as evidenced by a steep rise in the time-activity curve over 
the gallbladder ROI. This was typically preceded by an 
increase in activity in the proximal bile duct ROI, and 
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accompanied by a simultaneous plateau of bile duct activity. 
4) On initial filling, activity rapidly reached the fundus 
of the gallbladder, traveling along its long axis, and then 
spread laterally. From these observations the authors 
concluded that: 1) Closure of the sphincter of Oddi was not 
required for gallbladder filling. 2) Filling occurs by a 
gradual buildup of bile in the proximal ducts, followed by 
abrupt entry into the gallbladder. 3) Initial flow of bile 
into the gallbladder occurs by a forceful process. They thus 
explained their results by proposing that gallbladder 
filling is likely due to motor activity of the gallbladder 
itself, and not dependent on biliary pressure generated by 
the sphincter of Oddi. 
In a discussion of this paper, however, Shreiner155 
argued that the experimental findings did not justify the 
authors' conclusion that the sphincter was not an important 
component in the filling process. He emphasized that: 1) 
"The fact that radioactivity appeared in the gallbladder at 
the same time after injection, whether or not radioactivity 
appeared in the duodenum, does not prove that the sphincter 
of Oddi was not closed during the filling phase of the gall¬ 
bladder," and 2) "Bile already present in the duct may 
prevent radioactivity from reaching the region of the 
[closed] sphincter before filling of the gallbladder." Van 
der Linden and Kempi interpreted the observed abrupt (as 
opposed to gradual) entry of bile into the gallbladder as 
evidence that muscular action (rather than passive flow 
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under pressure) was responsible for gallbladder filling. 
These two processes, however, are not necessarily mutually 
exclusive. The authors themselves stated that "although very 
informative on the flow of bile in the biliary tract, chole- 
scintigraphy does not permit any conclusion as to the nature 
of force responsible for that flow."154 This filling pattern 
could instead result from a steady buildup of pressure (due 
to a closed sphincter) suddenly overcoming flow resistance 
at the spiral valves of Heister. 
Scott et al.141 in 1985 measured gallbladder filling 
indirectly in fasting dogs. Under steady state conditions 
maintained by a continuous intravenous infusion of 
14C-labelled taurocholic acid (TCA), the investigators used 
a duodenal cannula to measure the rate of intestinal 
delivery of labelled TCA. Since both the rates of hepatic 
secretion and duodenal delivery of labelled bile acids could 
be quantified, the fraction of secreted bile entering the 
gallbladder could be calculated from the algebraic differ¬ 
ence of these two measurements. This allowed determination 
of the rate of gallbladder filling. In addition, implanted 
bipolar electrodes recorded intestinal myoelectric activity. 
Experiments were carried out first with the sphincter of 
Oddi intact, and then with the common bile duct cannulated, 
thereby eliminating any physiological effect of the 
sphincter, and producing a constant resistance to bile flow. 
Position of the papillary cannula was adjusted to simulate 
different common duct pressures (+5, 0, and -20 cm H20), and 
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thus determine the effect of biliary flow resistance on 
duodenal bile delivery. In all experiments, fasting duodenal 
bile acid delivery (and thus gallbladder filling and 
emptying) showed regular periodic variations, in conjunction 
with the MMC. Cannulation of the common duct did not abolish 
gallbladder filling or alter this pattern. The calculated 
gallbladder filling rate, however, was found to be propor¬ 
tional to the experimentally induced biliary flow resis¬ 
tance. The results of this study thus suggest that filling 
of the gallbladder during fasting is affected by, but not 
dependent upon, biliary pressure. Whether common duct 
pressure is mediated by action of the sphincter or the 
duodenal musculature cannot be inferred from this study, 
since cannulation of the duct would interfere with either 
mechanism. 
In 1988 Hutton et al.ee investigated the spontaneous 
passage of glass beads from canine gallbladders as well as 
changes in gallbladder ejection fraction after papillotomy. 
Papillotomy was performed through a duodenal incision using 
a standard papillotome. Quantitative cholescintigraphy was 
used to measure gallbladder ejection fraction before and at 
least one month after papillotomy. In this technique, 
computer acquisition was begun upon intravenous injection of 
3.0 mCi of 99mTc-PIPIDA, and intravenous cholecystokinin was 
administered once activity over the gallbladder reached a 
plateau. After gallbladder activity fell to a new constant 
level, ejection fraction was calculated from the difference 
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in counts between the two plateaus, divided by counts at the 
first plateau. Since the investigators were able to measure 
this parameter, gallbladder filling must have occurred, 
although no specific comment was made to this effect. In 
discussing observed decreases in gallbladder volume (both in 
the resting state and after stimulation with CCK) following 
papillotomy, Hutton et al. stated that "Although these 
reduced gallbladder volumes after sphincterotomy could be a 
result of impaired gallbladder filling, they seem more 
likely to be a result of improved emptying." The authors 
thus concluded that sphincter ablation produces a much more 
significant effect on gallbladder emptying than filling. 
Historically, medical scientists believed the sphincter 
of Oddi directed the flow of bile into the gallbladder. 
Multiple studies, however, have proposed the action of other 
physiologic mechanisms in this process. Table 7 summarizes 
the implications of these various experiments on gallbladder 
filling. With experimental evidence suggesting both active 
and passive modes of gallbladder filling, it is likely that 
these two processes operate in conjunction. Although the 
terminal common bile duct appears to play some role in the 
filling process, it is not clear whether its occlusive 
action is mediated by muscular constriction (either 
sphincteric, duodenal, or both) or some other mechanism, as 
yet undetermined. This investigation was designed to 
ascertain the role of the sphincter of Oddi in gallbladder 
filling in humans, by analyzing bile flow scintigraphically 
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in patients with an intact gallbladder and an ablated 
sphincter. With the development and widespread use of 
endoscopic papillotomy, the number of individuals with this 
specific anatomic configuration has greatly increased. In 
such persons, a single variable--the sphincter of Oddi--has 
been eliminated, providing an excellent model for studying 
the effect of this structure on bile flow. 
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Table 7: Summary of experimental data on the mechanism of gallbladder 
filling. 
Concl re: GB Filling 





Gopher 1925 Dog cannulate CBD No GB vis (IVC) + or + 
Copher et al. 1926 Dog rubber GB "GB" vis (IVC) + or + 
Burget 1926 Dog bypass SO, + drugs Nl pressure A's + 
Whitaker 1926 Doq SO ablation GB vis (IVC) - 
Cat SO ablation No GB vis (IVC) + 
Jones & Smith 1952 Human sphincteroplasty No GB vis (OCG) + 
Lempke 1960 Human sphincterotomy GB vis (OCG) - 
Tansy et al. 1974 Doq 1) cannulate CBD IGB bile flow + or + 
2) transect CBD j|GB bile flow + or + 
3) excise SO, duod Nl GB bile flow - 
Cohn et al. 1979 Dog sphincteroplasty 1) GB vis (IVC) - 
2) JGB volume ? 
Rosseland 1983 Rabbit papillotomy No GB vis (IVC) + 
Van der Linden 1984 Human guant HIDA 1) GB vis before ? 
distal CBD 
2) Abrupt GB fillinq ? 
Scott et al. 1985 Dog cannulate CBD, GB bile flow prop ? ? ? 
vary pressure to pressure 
Hutton et al. 1988 Doq papillotomy GB vis (PIPIDA) - 
Abbreviations: GB = gallbladder; CBD = common bile duct; SO = sphincter 
of Oddi; Duod = duodenum; IVC = intravenous cholangiography; OCG = oral 
cholecystography; vis = visualization, Nl = normal, | = decreased, A = 
change 
Conclusions: The results of each study are interpreted as either 
supporting (+) or opposing (-) the different possible mechanisms of 
gallbladder filling. A ? indicates that the experimental results 
suggest a particular conclusion, but offer no definitive support. 
Possible physiologic regulators controlling passive gallbladder filling 
include the sphincter of Oddi (SO) and the duodenal musculature (Duod). 
Please refer to the text for a full description of these studies. 

MATERIALS AND METHODS 
Subjects: 
Between June 3, 1987 and February 1, 1989, twelve 
patients with intact gallbladders underwent endoscopic 
papillotomy at Yale-New Haven Hospital. All of these 
individuals' personal physicians were contacted; the details 
of the study were explained, and permission to contact the 
patient was requested. Ten persons were contacted and 
invited to participate in the study. Two were lost to 
follow-up. Six people agreed to serve as experimental 
subjects. Of these, there were four females and two males, 
of ages 57, 66, 73, 77, 65, and 80, respectively. 
This study was approved by the Human Investigation 
Committee of the Yale University School of Medicine, the 
Yale-New Haven Hospital Radioisotope Committee, and the Yale 
University Radioactive Drug Research Committee. 
Experimental Protocol: 
All subjects were instructed to fast for at least four 
hours (preferably overnight) prior to beginning the study. 
On the day of the study, subjects were asked if they had 
experienced any symptoms of biliary disease (abdominal pain, 
fever, nausea, vomiting, bloating, jaundice, dark urine, or 
light stool) since the time of papillotomy. After giving 




cholescintigraphy as described below. Between the initial 
and delayed views, abdominal ultrasonography was performed 
to examine the gallbladder and to look for biliary air. 
Following completion of the scintigraphic study, an upright 
abdominal radiograph and a coned-down view of the right 
upper quadrant were obtained, also for determining the 
presence of air in the biliary tract. Lastly, a limited 
barium upper GI examination was done, in order to verify 
incompetence of the sphincter of Oddi by demonstration of 1) 
reflux of contrast from the duodenum into the common bile 
duct, and 2) free drainage of refluxed barium. All studies 
were performed in the Yale-New Haven Hospital Diagnostic 
Imaging facility. 
Endoscopic Papillotomy: 
All papillotomies were performed by the same 
gastroenterologist, using an Olympus JFV-10 side-viewing 
endoscope, a Zimmon papillotome, and an Olympus UES 
Electro-surgical unit. Indications for papillotomy included 
choledocholithiasis in four patients (causing ascending 
cholangitis in one patient and gallstone pancreatitis in 
another), pancreatitis (possibly due to pancreatic divisum 
or sphincter of Oddi spasm) in one patient, and sphincter of 




Scintigraphy was performed using 5.0 mCi (185 MBq) of 
g9mtc-DISIDA (disofenin), N,a-(2,6,-diisopropylacetanilide)- 
iminodiacetic acid (Hepatolite; New England Nuclear, North 
Billerica, Massachusetts), as the tracer. Images were 
obtained with a Siemens ZLC large field of view 
scintillation camera outfitted with a low-energy all-purpose 
(LEAP) parallel hole collimator. After an initial flow 
study, serial anterior 500,000 count scintigrams were 
obtained at five minute intervals for 45 minutes, with 
delayed views taken at one to four hours as needed. 
Additional left anterior oblique (LAO), right anterior 
oblique (RAO), and right lateral views were obtained between 
45 and 60 minutes post-injection. 
Quantification of cardiac and hepatic uptake and 
hepatic excretion was performed with a Picker 512-PCS 
computer, acquiring images in a 64 X 64 matrix. Regions of 
interest (ROI) were selected over the heart and liver. The 
liver ROI was positioned so as not to include bile ducts or 
gallbladder. Perfusion curves were generated by plotting the 
number of counts in each ROI over the first 120 seconds 
after injection of tracer (see Figures 16A, 22A, & 25A). 
Hepatic excretion curves were generated by plotting the 
number of counts within the liver ROI over the initial 45 
minutes of the study. The half-time hepatic clearance was 
determined from the slope of the time-activity curve over 
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the liver ROI (see Figures 16B, 22B, & 25B), from the time 
of peak activity in this region until the end of the period 
of computer acquisition of data (45 minutes). The slope of 
the curve was calculated using a single exponent least- 
squares fit. The computer program automatically corrected 
for radioactive decay of the isotope. Normal range for 
half-time clearance is 16-24 minutes (based on data from 30 
normal volunteers studied at Yale-New Haven Hospital during 
1978-1980). All cholescintigraphic studies were reviewed by 
the attending nuclear medicine staff member. 
Ultrasonography: 
Real-time ultrasonography was performed using an ATL 
600 ultrasound scanner, equipped with a 3 MHz sector-display 
transducer (Advanced Technology Laboratories, Seattle, 
Washington). Images of the liver, gallbladder, and common 
bile duct were obtained. Sonograms were taken in the supine, 
left lateral decubitus, and erect positions. The right and 
left lobes of the liver were scanned for the presence of air 
in the intrahepatic bile ducts. The finding of echogenic 
foci within the liver parenchyma, accompanied by "dirty" 
acoustic shadowing,156 (see Figure 7) was considered 
evidence of intrabiliary air. All sonograms were performed 




Upper GI Examination: 
Fluoroscopy was performed following ingestion of barium 
sulfate. When possible, the following maneuvers were 
employed in order to maximize the probability of contrast 
flow into the common bile duct: 1) repeated turning of the 
subjects, 2) prone and Trendelenburg positioning (placing 
the papilla of Vater in a dependent position), and 3) 
abdominal compression. Multiple radiographs were taken as 
barium flowed through the duodenum. All films were reviewed 
by a gastrointestinal radiologist. 

RESULTS 
The gallbladder was seen on cholescintiscan in three 
(50%) of the six subjects. One subject (17%) demonstrated 
rapid excretion of tracer from the liver (half-time 
clearance of 11 minutes, as compared to the normal value of 
16-24 minutes). Hepatic excretion was delayed (clearance 
half-time from 27-54 minutes) in the remaining five subjects 
(83%). Air in the biliary tract was noted in three subjects 
(50%) on both sonography and plain abdominal radiography. No 
air was seen on plain film or ultrasound in the other three 
subjects (50%). Barium examination revealed reflux of 
contrast from the duodenum into the common bile duct in two 
subjects (33%). Both subjects with demonstrable barium 
reflux had evidence of biliary air on plain film and ultra¬ 
sonography, and one showed rapid clearance of tracer from 
the liver. One subject had evidence of biliary air on both 
plain film and ultrasound, but no observable reflux of 
barium. All six subjects reported that they had been 
completely free of biliary symptoms since papillotomy. 
Thus, radiologic confirmation of sphincter of Oddi 
incompetence was obtained in only three subjects (50%). The 
remaining three subjects demonstrated no biliary air by 
plain film or sonography, no contrast reflux, and delayed 
hepatic clearance of tracer. Filling of the gallbladder on 
scintigraphy was seen in one (33%) of the three subjects 




sphincter. Visualization or nonvisualization of the gall¬ 
bladder by cholescintigraphy did not correlate with any of 
the other variables measured (estimated papillotomy incision 
size, time since papillotomy, biliary air on plain film or 
ultrasonography, contrast reflux into the common bile duct, 
99mTc-DISIDA hepatic clearance half-time, and post¬ 
papillotomy clinical history). 
The results are summarized in table 8, and the 
individual case histories and findings are described below. 
Reference normal values for laboratory tests mentioned below 
are as follows: alkaline phosphatase: 10-70 units/1, total 
bilirubin: less than 1.50 mg/dl, direct bilirubin: less than 
0.30 mg/dl, serum glutamic-oxaloacetic transaminase (SGOT): 
15-35 units/1, serum glutamic-pyruvic transaminase (SGPT): 
less than 32 units/1, amylase: 40-150 units/dl, lipase: less 


























1 1 cm 4.5m Yes Yes Yes Yes 40 min. No 
2 1.5+ cm 4m No Yes Yes Yes 11 min. No 
3 1 cm 7.5m Yes No No No 54 min. No 
4 1.5 cm lm Yes* No No No 27 min. No 
5 1 cm 21m No* No No No 31 min. No 
6 1.0 cm 2m No* Yes Yes No 44 min. No 
Abbreviations: Subj = subject number, Pap Size = estimated length of 
papillotomy incision; Post-Pap Time = Time since papillotomy (in 
months); GB vis = visualization of the gallbladder by cholescintigraphy; 
Air on XR = biliary air noted on abdominal plain film; Air on US = 
biliary air detected by ultrasonography; CBD Reflux = reflux of barium 
from the duodenum into the common bile duct on upper GI exam; Clear 
Half-Time = calculated half-time for clearance of radiopharmaceutical 
from the liver ROI (normal = 16-24 min.); Post-Pap Sx = persistence of 
the subjects' original presenting symptoms (as described in the 
individual case histories), or other complaints attributable to the 
biliary system (RUQ pain, fever, nausea, vomiting, jaundice, dark urine, 
acholic stools) following endoscopic papillotomy. 
* These subjects demonstrated gallbladder visualization on a previous 
cholescintiscan. Prior scans were performed two weeks before papillotomy 
in subject #4, six years before papillotomy in subject #5, and two days 
before papillotomy in subject #6. 
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Case 1: An 80 year old male presented to Yale-New 
Haven Hospital on Sept. 14, 1988, with complaints of right 
upper quadrant abdominal pain, nausea and vomiting, and 
fever (101.8°F). He was not jaundiced, and had noted no 
change in urine or stool color. He had been hospitalized for 
right upper quadrant pain and jaundice on three previous 
occasions in the last eleven years. Gallstones were 
documented by ultrasound in the past. Past medical history 
was notable for a subtotal gastrectomy with Bilroth II 
anastomosis, an old anterior wall MI, exertional angina, and 
three CVA's, the most recent one occurring one week before 
admission. Admission labs included: WBC 15,600 cells/mm3, 
alkaline phosphatase 269 units/1, total bilirubin 1.8 mg/dl 
(direct 0.6 mg/dl), SGOT 519 units/1, amylase 52 units/dl, 
and lipase 0.3 units/ml. The patient was diagnosed as having 
ascending cholangitis, likely secondary to an obstructing 
common duct stone, and was treated initially with hydration 
and antibiotics. He remained febrile, developed dark urine 
and acholic stools, and serum total bilirubin increased to 
4.4 mg/dl (direct 2.7 mg/dl). Due to the increased risk of 
surgery following a recent CVA, the patient was referred for 
endoscopic papillotomy on Sept. 16, 1988. ERCP demonstrated 
a non-dilated biliary tree with a single common duct stone 
and several stones in the gallbladder (see Figure 6). A 1 cm 
incision was made and the stone was crushed and removed with 
a Dormia basket. The patient defervesced following stone 
extraction, and was discharged three days later. 
. 
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Subject #1 participated in the research protocol on 
Feb. 1, 1989 (4.5 months after papillotomy). Since the 
papillotomy he had experienced no symptoms of biliary 
disease. The gallbladder visualized on cholescintigraphy 
(see Figure 7), first appearing at 20 minutes post¬ 
injection. The study was carried out to 3.75 hours, at 
which time the isotope had fully cleared from the liver. 
Hepatic excretion was delayed, with a half-time clearance of 
40 minutes. Sonography demon-strated both stones and air in 
the gallbladder and air in the intrahepatic bile ducts (see 
Figure 8). Abdominal plain film showed air in the biliary 
tree (see Figure 9). Reflux of barium from the duodenum into 
the common bile duct was noted on upper GI exam (see Figure 
10). The contrast drained immediately from the biliary 
system, since the duct was not evident on a repeat radio¬ 
graph taken less than one minute later. 
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Figure 6: Subject #1: ERCP film showing filling 
of the cystic duct and gallbladder with 




Figure 7; Subject #1: 99mTc-DISIDA cholescintigraphic images 
showing: (A) activity in the liver, gallbladder (G), and bowel at 45 
minutes; and (B) activity in the gallbladder (g) and bowel, with 
nearly complete clearance of tracer from the liver, at 2 hours. 
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Figure 8: Subject #1: Ultrasound images of: (A) the gallbladder, 
containing gallstones [echogenic foci (small arrows) with complete 
acoustic shadowing (S)] in the dependent portion, and air [echogenic 
foci (large straight arrow) with "dirty" shadowing (curved arrow)] in 
the non-dependent portion; and (B) the liver, with air in the intra- 
hepatic bile ducts [echogenic foci (arrow) with shadowing (S)]. 
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Figure 9: Subject #1: Plain abdominal film 




Figure 10: Subject #1: 
(A) Film demonstrating 
reflux of barium from the 
duodenum into the common 
bile duct (straight arrow) 
on upper GI exam. Note also 
the presence of air in the 
proximal biliary tree 
(curved arrow). This subject 
had undergone a subtotal 
gastrectomy with Bilroth II 
anastomosis. (B) Detailed 
view of the biliary tract 




Case 2: A 66 year old female was admitted on Sept. 15, 
1988, complaining of six weeks of intermittent upper 
abdominal pain, pruritis, jaundice, dark urine, and light 
stools. She had a history of morbid obesity, non-insulin 
dependent diabetes mellitus, and hypertension. She was 
afebrile, and had icteric sclerae. Labs on admission were 
remarkable for: total bilirubin 19.7 mg/dl (direct 11.2 
mg/dl), SGOT 163 units/1, and alkaline phosphatase 264 
units/1. Calcified gallstones, including one stone in the 
region of the cystic duct (see Figure 12), were noted on a 
plain abdominal film. Ultrasonography revealed a small gall¬ 
bladder with multiple stones, a dilated common bile duct 
measuring 10 mm (normal 6mm or less87 ), and normal caliber 
intrahepatic ducts. CT scan also showed a small gallbladder 
with stones, and stones in the common hepatic and common 
bile ducts (see Figure 11). The patient was diagnosed as 
having obstructive jaundice secondary to choledocholith- 
iasis. Endoscopic papillotomy was opted for because her 
extreme obesity represented a contraindication to surgery. 
ERCP on Sept 19, 1988 demonstrated a mildly dilated common 
hepatic duct, with two ductal stones (see Figure 12). The 
cystic duct and gallbladder did not visualize with contrast. 
A 1.5 cm papillotomy was made, but attempts at stone extrac¬ 
tion were unsuccessful. An internal stent was placed to 
maintain drainage (see Figure 13). The patient improved 
clinically and was discharged two days later. She was 
readmitted on Oct. 9, 1988, for a repeat ERCP and stone 
■ ' 
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extraction. ERCP on Oct. 11, 1988 revealed multiple common 
duct stones and biliary air, and filling of the cystic duct 
(see Figure 14). The papillotomy was extended and the stent 
removed. Only one stone could be extracted. Subsequently the 
patient experienced several bouts of right upper quadrant 
pain accompanied by transient elevations of liver function 
tests. This was presumed to be due to passage of stones. 
Serial abdominal plain films revealed that some of the 
gallstones had indeed passed. The patient improved and was 
discharged on Oct. 19, 1988. 
Subject #2 participated in the research protocol on 
Feb. 8, 1989 (four months after papillotomy). Since the 
papillotomy she had had no symptoms of biliary disease. The 
gallbladder did not visualize on cholescintigraphy (see 
Figure 15). The study was carried out to two hours, at which 
time the liver activity had completely cleared. Hepatic 
clearance was rapid, with a half-time of 11 minutes (see 
Figure 16). Sonography revealed a small gallbladder 
containing stones (see Figure 17A), and air in the intra- 
hepatic bile ducts (see Figure 17B). Plain film demonstrated 
air in the biliary tree (see Figure 18). Reflux of barium 
from the duodenum into the common bile duct was noted on 
upper GI exam (see Figure 19). The contrast drained 
immediately from the biliary system. 
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Figure 11: Subject #2: CT scan showing (A) calcified stones (arrows) 
in the common hepatic duct; and (B) a small gallbladder (curved 
arrow) containing a stone, and a calcified stone (straight arrow) in 
the intra-pancreatic portion of the common bile duct. 
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Figure 12: Subject #2: 
Pre-papillotomy ERCP 
film showing two stones 
(arrows) in the common 
duct, and no filling of 
the gallbladder with 
contrast. 
Figure 13: Subject #2: 
Post-papillotomy 
abdominal film showing 
an internal biliary 
stent (open arrow), 
calcified stones in the 
common duct, a stone in 
the region of the 
cystic duct (straight 
arrow), and stones in 




Figure 14: Subject #2: 
Repeat ERCP films (one 
month after papillotomy) 
demonstrating: 
(A) Multiple stones in 
the common duct and air 
(arrow) in the intra- 
hepatic bile ducts. 
(B) filling of the 







Figure 15: Subject #2: 99mTc-DISIDA scan at (A) 40 minutes, showing 
tracer in the liver, bile ducts (d), and bowel (b), with no activity 
in the gallbladder fossa (f). (B) On 1 hour image (RAO view), most 
of the liver activity has cleared, tracer remains in the bile ducts 
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Figure 16: Subject #2: (A) 99mTc-DISIDA perfusion curves showing the 
bolus of tracer in the cardiac blood pool, and uptake of isotope by 
the liver. (B) Hepatic excretion curve demonstrating rapid clearance 
of tracer from the liver. The bars on the x-axis delineate the 
portion of the curve used to calculate the clearance half-time. 
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Figure 17: Subject #2: Ultrasound images showing (A) a small 
contracted gallbladder containing stones [echogenic focus (arrow) 
with prominent acoustic shadowing (S)]; and (B) a normal common 
bile duct (arrowheads), and air in the intrahepatic ducts (arrow). 
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Figure 18: Subject 
#2: Abdominal plain 
film showing a 
single stone in the 
gallbladder (curved 
arrow) and air in 
the biliary tree 
(straight arrows). 
Figure 19: Subject 
#2: Upper GI exam 
demonstrating 
reflux of contrast 
from the duodenum 
into the common 
bile duct (arrows). 
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Case 3: A 57 year old female was admitted on June 28, 
1988, complaining of multiple bouts of upper abdominal pain 
over the past year. She had not experienced jaundice, 
nausea, vomiting, bloating, change in urine or stool color, 
or fever. She had a history of several episodes of abdominal 
pain and chronically elevated transaminases and amylase 
(which had recently returned to normal). A previous gall¬ 
bladder ultrasound, abdominal CT scan, and oral cholecysto- 
gram were all normal. Admission labs included: alkaline 
phosphatase 55 units/1, total bilirubin 0.86 mg/dl (direct 
0.11 mg/dl), SGOT 37 units/1, SGPT 80 units/1, and amylase 
169 units/dl. She was given a presumptive diagnosis of 
sphincter of Oddi spasm, and was referred for ERCP and 
papillotomy. ERCP on June 28, 1988 revealed normal bile 
ducts and gallbladder (see Figure 20), and a pancreas 
divisum. A 1 cm papillotomy was made, through which an 8 mm 
balloon was passed. The patient developed post-ERCP 
pancreatitis on the following day, with amylase rising to 
1900 units/dl and lipase increasing to 330 units/ml. This 
resolved with medical treatment, and she was discharged on 
July 5, 1988. 
Subject #3 participated in the research protocol on 
Feb. 16, 1989 (7.5 months after papillotomy). Since her last 
hospitalization she had not experienced symptoms of biliary 
or pancreatic disease. The gallbladder visualized on 
cholescintiscan at 20 minutes (see Figure 21). Hepatic 
. 
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excretion was delayed, with a half-time clearance of 54 
minutes (see Figure 22). Sonography revealed a normal 
gallbladder, common bile duct, and liver, with no evidence 
of biliary air. No air was noted on plain film, and barium 
study showed no reflux into the common bile duct. Liver 
function tests ordered by her personal physician on the 
following day were all within normal limits (SGOT 27 





Figure 20: Subject #3: ERCP film demonstrating 
a normal biliary system and filling of the 
cystic duct and gallbladder with contrast. 
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Figure 21: Subject #3: 99mTc-DISIDA scan showing (A) activity in the 
gallbladder (arrow) at 20 minutes; (B) visualization of the gall¬ 
bladder (g) and bile ducts (d) at 45 minutes; and (C) clearance of 
isotope from the liver, with tracer remaining in the gallbladder (g) 
and bowel (b) at 90 minutes. (Figure continues on next page.) 
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Figure 21: (cont.) Subject #3: (C) Delayed (90 
minute) cholescintigraphic image, showing tracer 
in the gallbladder (g) and bowel (b). 
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Figure 22: Subject #3: (A) "mTc-DISIDA perfusion curves showing the 
bolus of tracer in the cardiac blood pool, and uptake of isotope by 
the liver. (B) Hepatic excretion curve demonstrating markedly delayed 
clearance of tracer from the liver. The bars on the x-axis delineate 
the portion of the curve used to calculate the clearance half-time. 
■ 
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Case 4: A 77 year old female was admitted on Jan. 31, 
1989, complaining of several episodes of postprandial 
abdominal pain and nausea over the past six to eight months. 
She had no complaints of jaundice, dark urine, or light 
stools. Mild elevations of amylase and lipase were noted 
during one previous episode of right upper quadrant pain. A 
prior ultrasound showed a distended gallbladder with no 
stones, and a dilated common bile duct measuring 9.5 mm 
(normal 6 mm or less87 ) which increased to 11.5 mm following 
a fatty meal. The intrahepatic ducts were not dilated. A 
previous cholescintiscan (see Figure 23) visualized the 
gallbladder at 30 minutes. Hepatic uptake and excretion were 
normal (half-time clearance 23 minutes), but appearance of 
tracer in the bowel was delayed (absent at 45 minutes, but 
present at 90 minutes), suggestive of bile stasis in the 
common duct. A prior ERCP had also been attempted. The 
pancreatic duct did not opacify upon cannulation of the 
major papilla, but visualized after cannulation of the 
accessory papilla (evidence of a pancreas divisum). The 
patient was given a diagnosis of sphincter of Oddi stenosis, 
and referred for ERCP and papillotomy. Additional past 
medical history was notable for hypertension, mitral valve 
prolapse, degenerative joint disease, and several minor 
surgeries. Laboratory studies on admission included: total 
bilirubin 0.31 mg/dl (direct 0.03 mg/dl), SGOT 19 units/1, 
amylase 94 units/dl, lipase 0.2 units/ml, and WBC 6,700 




dilated common bile duct (see Figure 24), and no filling of 
the pancreatic duct. No stones were seen. Papillotomy was 
begun with a precut papillotome, and the incision was 
extended to 1.5 cm after threading the cannula over a guide- 
wire. The patient did well after the procedure and was 
discharged on the following day. 
Subject #4 participated in the research study on Mar. 
3, 1989 (one month after papillotomy). Since that time she 
had been completely free of biliary symptoms. Cholescinti- 
graphic findings were nearly identical to those of her pre¬ 
papillotomy scan. The gallbladder visualized at 15 minutes. 
Hepatic uptake was normal, and excretion was borderline 
delayed, with a half-time clearance of 27 minutes (see 
Figure 25). Excretion from the common duct was also delayed. 
No bowel activity was present at 45 minutes (see Figure 
26A), but a delayed view (2 hr) demonstrated complete 
clearance of the liver and visualization of the bowel (see 
Figure 26B). No biliary air was evident on plain film or 
ultrasound, and reflux of barium into the common duct did 
not occur. Ultrasound revealed a dilated common bile duct 
measuring 8 mm (see Figure 27). 
■ 
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Figure 23; Subject #4: Pre-papillotomy 9 9Tc-DXSIDA scan showing (A) 
tracer in the liver, common duct (d), and gallbladder (g) at 35 minutes; 
and (B) activity in the gallbladder (g) and bowel (b) at 90 minutes. 
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Figure 24: Subject #4: ERCP film showing a 
dilated common hepatic duct (d) and filling of 
the gallbladder with contrast. The finding of 
a dilated common duct and delayed drainage of 
contrast from the biliary tree, in the absence 
of an obstructing lesion, is consistent with 
sphincter of Oddi stenosis. 
■ 
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Figure 25: Subject #4: (A) 99"Tc-DISIDA perfusion curves showing the 
bolus of tracer in the cardiac blood pool, and uptake of isotope by 
the liver. (B) Hepatic excretion curve demonstrating mildly delayed 
clearance of tracer from the liver. The bars on the x-axis delineate 
the portion of the curve used to calculate the clearance half-time. 
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Figure 26: Subject #4: Post-papillotomy 99mTc-DISIDA scan showing: 
(A) activity in the liver, common duct (d), and gallbladder (g) at 




Figure 27: Subject #4: Ultrasound image demonstrating a 
dilated common bile duct measuring 8 mm (normal = 6 mm 




Case 5: A 72 year old female presented with fever 
(103°F), right upper quadrant pain, nausea, and vomiting, on 
May 29, 1987. She was not jaundiced and had no change in 
urine or stool color. She had experienced a similar episode 
earlier that month, which resolved on antibiotics. Ultra¬ 
sound at that time did not demonstrate gallstones. Chole- 
scintiscan (see Figure 28) showed a high grade common duct 
obstruction, with no visualization of the ducts, gall¬ 
bladder, or bowel at four hour delay (non-diagnostic for 
acute cholecystitis). The patient had also undergone chole- 
scintigraphy in 1981 (see Figure 29), which demonstrated a 
normal gallbladder first visualized at 25 minutes. Past 
medical history was notable for morbid obesity (370 lbs), 
hypertension, asthma, and non-insulin dependent diabetes 
mellitus. Admission labs included: amylase 816 units/dl, 
lipase 5.2 units/ml, alkaline phosphatase 120 units/1, SGOT 
52 units/1, total bilirubin 1.02 mg/dl (direct 0.54 mg/dl), 
and WBC 7,300 cells/mm3 . She was thought to have cholangitis 
and gallstone pancreatitis. She was judged to be an 
unacceptable risk for general anesthesia because of her 
asthma and obesity, and was thus referred for ERCP and 
possible papillotomy. ERCP on June 3, 1987 revealed a stone 
in the common bile duct and several stones in the gall¬ 
bladder (see Figure 30). A 1 cm papillotomy was made, and 
the ductal stone was extracted. She improved clinically and 
was discharged after two days. Nine months later she 
successfully underwent a total abdominal hysterectomy and 
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bilateral salpingo-oophorectomy for endometrial carcinoma, 
and has since recovered. 
Subject #5 participated in the study on Mar. 14, 1989 
(21 months after papillotomy). She denied any interim 
biliary symptoms. The gallbladder did not visualize on 
cholescintiscan (see Figure 31). The study was carried out 
to 2.25 hours, by which time liver activity had completely 
cleared. Nonvisualization of the gallbladder was confirmed 
by placing a radioactive marker on the skin over the 
position of the gallbladder (as determined by sonography). 
Hepatic uptake was normal, and excretion was delayed, with a 
half-time clearance of 31 min. Ultrasound revealed a 
thickened gallbladder wall (see Figure 32) measuring 6 mm 
(normal wall thickness is 2 mm or less87), and no biliary 
air. No air in the biliary tract was seen on plain abdominal 
film. Reflux of barium into the common duct did not occur. 
Of note, the contrast study in this subject could not be 
performed under optimal conditions, since her large size 
inhibited her mobility and prevented her from lying prone. 
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Figure 28: Subject #5: 99mTc-DISIDA scan (delayed four hour image) 
performed one month before papillotomy (1987) showing activity only 
in the liver, with no visualization of the common duct, gallbladder, 
or bowel. This finding is consistent with complete biliary 
obstruction, and is non-diagnostic for acute cholecystitis. 
Figure 29: Subject #5: 99mTc-DISIDA scan from 1981 (six years 
before papillotomy), showing visualization of the gallbladder 
(straight arrow) and common duct (curved arrow). 
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Figure 30: Subject #5: ERCP film showing a stone 
(straight arrow) in the common bile duct and a 
contrast-filled gallbladder (curved arrows) 
containing multiple faceted gallstones. 
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Figure 31: Subject #5: 
Post-papillotomy 
9 9 m Tc-HIDA scan (2 hr 
image) showing tracer 
in the bowel (b), and 
no visualization of 
the gallbladder. A 
radioactive marker 
(arrow) was placed 
over the position of 
the gallbladder, as 
determined by 
ultrasound. 
Figure 32: Subject 
#5: Ultrasound of 
the gallbladder, 
showing a thickened 
wall, measuring 6 
mm (normal = 2 mm 
or less). Arrow 
points to cursors 




Case 6: A 65 year old male was admitted on Jan. 18, 
1989, complaining of sharp mid-epigastric pain over the last 
four days, accompanied by mild fever. The patient had 
experienced several episodes of similar pain over the past 
20 years. He noted no nausea, vomiting, jaundice, dark 
urine, or acholic stools. The patient was anicteric and 
afebrile. Past medical history was notable for a Schatzke 
ring and benign prostatic hypertrophy. The patient was 
initially seen at another hospital. An ultrasound revealed a 
dilated common bile duct and possible hydrops of the gall¬ 
bladder. No stones were seen. A cholescintiscan showed no 
excretion from the liver at two hours. On delayed (19 hour) 
view the gallbladder and bowel were visualized. The patient 
then came to Yale-New Haven Hospital for further work-up and 
treatment. Laboratory studies on admission revealed alkaline 
phosphatase 434 units/1, total bilirubin 0.82 mg/dl (direct 
0.16 mg/dl), SGOT 197 units/1, SGPT 400 units/1, amylase 95 
units/dl, lipase 0.6 units/ml, and WBC 6,000 cells/mm3 . An 
ERCP was performed on Jan. 19, 1989. Cholangiogram revealed 
a single filling defect in the distal common bile duct, and 
several filling defects in the right and left hepatic ducts. 
The common duct was not dilated. The cystic duct and gall¬ 
bladder filled with contrast, and no stones were seen in the 
gallbladder. A 1.0 cm papillotomy was performed, after which 
a single small stone passed spontaneously through the 
papilla. The patient developed post-ERCP pancreatitis on the 
following day, with an amylase of 3240 units/dl and lipase 
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65.0 units/ml. He recovered over the next few days, and was 
discharged on Jan. 24, 1989. 
Subject #6 participated in the study on Mar. 31, 1989 
(two months after papillotomy). Since the papillotomy he had 
experienced no biliary symptoms. The gallbladder was not 
seen on scintigraphy. By two hours post-injection nearly all 
tracer had cleared the liver. Delayed anterior and right 
lateral views showed an anterior area of concentrated 
activity in the region of the gallbladder. However, this 
activity cleared after the subject drank a glass of water, 
and thus was demonstrated to be due to pooling of tracer 
within a loop of bowel. Hepatic clearance half-time was 44 
minutes (delayed). Ultrasound revealed air in the intra- 
hepatic bile ducts. No stones were seen in the gallbladder. 
Air in the biliary tree was also seen on plain film. No 
reflux into the common bile duct was noted on upper GI exam. 
Liver function tests drawn on the day of the study were all 
within normal limits: alkaline phosphatase 96 units/1, total 
bilirubin 0.98 mg/dl (direct 0.22 mg/dl), SGOT 38 units/1, 
and SGPT 40 units/1. 
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DISCUSSION 
It is difficult to draw definitive conclusions from the 
results of this investigation, because of the small number 
of subjects involved. This is related to the specific 
population studied. Although an increasing percentage of 
individuals with an intact gallbladder are being treated 
with endoscopic papillotomy, the number of such persons seen 
at any one institution is not large. In addition, most 
series reporting a high percentage of patients with gall¬ 
bladders undergoing papillotomy are from European centers 
(see Table 4). So far, American physicians are apparently 
more inclined to refer such patients for cholecystectomy. A 
thorough search of Yale-New Haven Hospital records for the 
past two years (including reports from the radiology and 
gastroenterology departments, and hospital charts) revealed 
only twelve subjects suitable for this study (two of whom 
could not be reached). Many of these people are elderly 
and/or in relatively poor health (most were treated endo- 
scopically because of contraindications to surgery), making 
voluntary participation in a research study rather 
inconvenient. Taking this into consideration, it seems 
fortunate that six of the ten people contacted agreed to 
take part in the study. At any rate, the limited data 
obtained to this point raise several interesting questions, 
and allow preliminary conclusions as to the utility of 




Cholescintigraphy after Endoscopic Papillotomy: 
A major objective of this study was to determine if 
nonvisualization of the gallbladder by cholescintigraphy is 
a reliable indicator of cystic duct obstruction in post¬ 
papillotomy patients. In this series gallbladder nonvisual¬ 
ization occurred in three of six asymptomatic subjects who 
had undergone a previous endoscopic papillotomy. Although 
present data is limited, these results suggest a 50% false 
positive rate for cholescintigraphy in this population. This 
represents a dramatic reduction in specificity, and clearly 
undermines the utility of scintigraphy as a test for acute 
cholecystitis in patients with a prior endoscopic papil¬ 
lotomy. Using gallbladder nonvisualization as the sole 
diagnostic criteria, cholescintigraphy cannot distinguish 
acute cholecystitis from baseline conditions in perhaps half 
of these people. Of course, additional scintigraphic 
evidence of acute gallbladder disease may still be reliable 
in such patients, but such findings occur infrequently. 
These observations include: 1) the "rim sign" (increased 
pericholecystic activity) sometimes seen in gangrenous 
cholecystitis, gallbladder perforation, and severe gall¬ 
bladder inflammation;92 ■ 157' 1 59 and 2) a photopenic mass 
effect in the gallbladder fossa, occasionally observed in 




The ability to ascertain the functional status of the 
cystic duct is extremely helpful in confirming or excluding 
a diagnosis of acute cholecystitis. Cholescintigraphy is the 
only imaging modality capable of assessing cystic duct 
patency. While sonography is an excellent means of detecting 
gallstones, the presence of stones does not prove the 
existence of acute cholecystitis.92,94 In addition, many 
patients with an intact gallbladder after papillotomy have 
gallstones documented by prior studies. Using ultrasound to 
prove that the stones are still there is of questionable 
value. A negative ultrasound may prove helpful in demon¬ 
strating that prior stones have passed through the widened 
papillary orifice, but the clinical significance of finding 
stones on sonography is of limited usefulness in a patient 
with known gallstones. Ancillary sonographic findings (such 
as intramural sonolucency, pericholecystic fluid, sono¬ 
graphic Murphy's sign, gallbladder wall thickening, gall¬ 
bladder distention, and sludge) may be helpful in diagnosing 
acute cholecystitis, but they are not always present, and 
are often non-specific.92,94 
In summary, cholescintigraphy is the most appropriate 
diagnostic procedure in suspected cases of acute chole¬ 
cystitis. It is therefore important to know if the results 
of scintigraphic scanning are as accurate in post-papi1- 
lotomy patients as in the general population, especially 
since these individuals are potentially at high risk for 
both gallbladder disease and surgical complications. 
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Conclusions may be premature at this point, but the results 
of this small series suggest that cholescintigraphy is not 
a reliable test in this population. However, this study has 
also demonstrated that visualization of the gallbladder can 
occur in patients with a prior papillotomy (even in one case 
with radiographically documented incompetence of the 
sphincter of Oddi. Thus, a normal cholescintiscan in such a 
patient can exclude the possibility of acute cholecystitis, 
but a "positive" scan (i.e., nonvisualization of the gall¬ 
bladder) in a patient with an ablated sphincter of Oddi 
does not necessarily confirm this diagnosis. 
Routine Baseline Cholescintigraphy: 
In light of the apparently reduced accuracy of chole¬ 
scintigraphy in detecting acute cholecystitis following 
endoscopic papillotomy, it might prove useful to obtain 
baseline cholescintiscans in all individuals with an intact 
gallbladder after section of the sphincter of Oddi. This 
would provide diagnosticians with background results for 
comparison with future studies. In any person who demon¬ 
strates a normal baseline cholescintiscan following papil¬ 
lotomy, this imaging test can most likely be used with 
confidence to confirm or exclude the diagnosis of acute 
cholecystitis. However, in patients who do not show 
evidence of gallbladder filling after papillotomy, a 
subsequent "positive" cholescintiscan may in fact be related 
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to an incompetent sphincter of Oddi, as opposed to a blocked 
cystic duct. Baseline scintigraphy can therefore be employed 
to identify specific patients (i.e., those with gallbladder 
visualization) in whom subsequent cholescintigraphy would be 
of use should symptoms of acute gallbladder disease arise. 
Since the number of patients with an intact gallbladder 
after papillotomy represents only a very small segment of 
the population, the overall cost of obtaining baseline scans 
in these people should not be prohibitive. Whether such 
information is clinically useful depends upon the frequency 
of acute cholecystitis in post-papillotomy patients. This 
rate has varied widely (from 0-25%) in different follow-up 
studies.29.51-55.63.74.75, 77,02,83 combining the results of 
all these series gives an approximate 10% incidence of 
acute cholecystitis following endoscopic papillotomy. This 
risk is sufficiently high that obtaining routine post¬ 
papillotomy baseline scans may be warranted. Of course, 
baseline studies would only be useful if they provide 
reproducible results. It may be necessary to perform two or 
more scintiscans at set time intervals in a small group of 
subjects, in order to establish whether baseline findings 
remain stable. 
If persons particularly at risk for acute gallbladder 
disease could be identified, then baseline scintigraphy 
might prove particularly helpful in this subgroup. So far, 
however, no clear predictors of future gallbladder disease 
have been determined. Investigators have looked at ERCP 
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findings and the presence of gallstones in this 
context,56•80~83 but no studies have examined the possible 
value of scintigraphy as a predictor of long-term biliary 
complications. If nuclear imaging is routinely performed in 
post-papillotomy patients with an intact gallbladder, 
follow-up studies may eventually correlate long-term outcome 
with baseline cholescintigraphic findings. If this turns out 
to be the case, scintigraphy may be used to decide appro¬ 
priate patient care after endoscopic papillotomy. Persons 
with a normal baseline scan may be managed simply by out¬ 
patient follow-up, while those demonstrating nonvisualiza¬ 
tion of the gallbladder may be referred for prophylactic 
elective cholecystectomy. Elective surgery involves 
significantly lower morbidity and mortality as compared to 
emergency operation,14 • 17-19■2 2 and is certainly justified 
in patients at high risk for developing acute gallbladder 
disease in the future. The timing of scintigraphy following 
papillotomy is important. Early after transection of the 
sphincter, local edema may partially occlude the papilla, 
diminishing the size of the orifice. This temporary partial 
resistance to bile outflow may be sufficient to cause bile 
to enter the gallbladder. Baseline cholescintigraphy should 
be performed only after the incision has healed and early 
edema has subsided. The healing process should be complete 
by one month. 
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Possible Explanations for Gallbladder Visualization: 
Despite prior endoscopic papillotomy, gallbladder 
filling occurred in three subjects in this study (50%), as 
demonstrated by scintigraphy. If contraction of the 
sphincter of Oddi is necessary for the gallbladder to fill, 
the observed normal cholescintiscans in these persons could 
have resulted from either: 1) residual contractility 
following only partial destruction of the sphincter by 
papillotomy; and/or 2) healing or restenosis of the 
sphincter. Endoscopic papillotomy does not necessarily 
result in total ablation of the sphincter of Oddi. This 
procedure is performed in order to treat a particular 
problem; such as choledocholithiasis, or symptoms attributed 
to papillary stenosis. Incomplete section of the sphincter 
may be sufficient to allow stone extraction and/or relieve a 
person's symptoms. Thus, following papillotomy, some 
patients might be left with a partially ablated (as opposed 
to a completely non-functional) sphincter of Oddi. In such 
cases, the remaining sphincteric activity may be adequate to 
at least partly occlude the common bile duct, thereby 
diverting bile into the gallbladder and preventing reflux of 
air or contrast into the biliary tract. 
Endoscopic manometry of the biliary tree is the 
definitive method of assessing sphincter of Oddi physio- 
logy.137*138*160 This technique has been widely used to 
evaluate patients with persistent abdominal pain following 
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cholecystectomy, the so-called "post-cholecystectomy 
syndrome."6,161*167 The results of manometric studies 
suggest that anatomic and/or functional disorders of the 
sphincter of Oddi may be responsible for such symptoms in 
some of these individuals. A plethora of terms (such as 
papillary stenosis, ampullary stenosis, stenosing papil¬ 
litis, fibrotic Odditis, spastic sphincter of Oddi, hyper¬ 
tonic Oddi's sphincter dyskinesia, biliary dyskinesia, and 
others) have been used to describe these entities, which 
can be collectively referred to as sphincter of Oddi dys¬ 
function . 1 6 5 * 1 6 6 Findings of elevated basal pressures in the 
common duct and region of the sphincter of Oddi, as well as 
an elevated common duct-to-duodenum pressure gradient, 
provide objective evidence of sphincter stenosis or 
dysmotility.6 • 16 1 * 1 6 7 
Several investigators have used endoscopic manometry to 
examine the effect of surgical sphincteroplasty and endo¬ 
scopic papillotomy on biliary pressures.161*163,167*173 All 
of these studies reported a striking reduction in mean basal 
sphincter of Oddi pressure and common duct-to-duodenum 
pressure gradient following endoscopic papillotomy. Although 
biliary manometry represents the current "gold standard" for 
evaluating the presence or absence of sphincter activity, it 
is an invasive procedure that is not widely available. As an 
alternative, non-invasive imaging methods have often been 
used to verify incompetence of the sphincter of 
Oddi.12,52,56,70,78,135,153,163 These include: 1) examine- 
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tion of plain abdominal films for the presence of air in the 
biliary tree, and 2) upper GI studies to demonstrate reflux 
of contrast material from the duodenum into the common bile 
duct. Escourrou et al.52 performed abdominal radiography and 
barium studies in 60 post-papillotomy patients. They noted 
biliary air in 70% of persons and common duct reflux in 65% 
of patients. Cotton observed these radiographic findings in 
"about two thirds of patients" following papillotomy.56 
Winstanley et al.78 noted bile duct gas on plain film in 14 
(41%) of 34 patients at long-term (18 months to five years) 
follow-up examination. They also noted air on ultrasound in 
ten individuals, although only five of them had evidence of 
biliary air on plain film. The authors concluded that 
"Although gas was observed in only 41% of cases, it may have 
been present and undetected in many more, as suggested by 
the results of the ultrasound examinations." 
This investigation employed all of these radiologic 
methods (plain film, sonography, and limited upper GI 
examination) to assess the status of the sphincter of Oddi. 
Imaging studies revealed evidence of an incompetent 
sphincter in only three (50%) of six subjects. The meaning 
of these findings is unclear, however, because the sensi¬ 
tivity of these imaging techniques in detecting sphincter 
incompetence has never been determined. In one study,163 
eight patients with radiographic evidence of biliary air 
after endoscopic papillotomy were tested with manometry. All 
eight persons had basal sphincter pressures of 0 mm Hg. 
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These results suggest that (in the absence of biliary- 
enteric fistulae) the finding of air in the biliary tree is 
highly specific for a non-functional sphincter of Oddi. 
However, no conclusions regarding the sensitivity of this 
finding can be drawn from this small series, since post¬ 
papillotomy manometry was not performed on patients in whom 
biliary air was not seen. Thus, while the presence of air or 
contrast reflux are highly suggestive of an incompetent 
sphincter of Oddi, the inverse may not be true. Lack of 
these findings does not necessarily prove that the 
sphincter is functioning normally. 
Investigators have also studied the possible occurrence 
of healing and restenosis of the sphincter of Oddi after 
endoscopic papillotomy. Geenen et al.173 measured the change 
in size of papillotomy incisions at twelve and 24 month 
follow-up examinations. They noted a slight decrease in 
incision length (from a mean of 11.6 mm to 8.3 mm) in 22 
patients after one year, and a lower reduction in size (from 
a mean of 7.5 mm to 6.5 mm) in eight persons between one and 
two years after papillotomy. Follow-up manometry documented 
dramatically diminished basal sphincter of Oddi pressure 
and common duct-to-duodenal pressure gradient (as compared 
to pre-papillotomy values), in all subjects. The authors 
obtained consistent and reliable estimates of papillotomy 
incision length by 1) gauging the size of the orifice in 
reference to the diameter of the papillotome catheter, and 
2) passing balloon catheters inflated to a known diameter 
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through the papillary opening. This study suggests that, 
although some healing of the incision takes place over time, 
endoscopic papillotomy likely results in a substantial 
disruption of sphincter of Oddi contractility for at least 
two years. 
Restenosis of the sphincter of Oddi has been described 
after endoscopic papillotomy, but this occurs very rarely, 
with a reported incidence of 0.9-4.3%.36 * 41 ■ 75* 7 7 Of note, 
one follow-up study found a greater incidence (2 [8.3%] of 
24 patients) of restenosis in persons treated endoscopically 
for sphincter of Oddi stenosis, as compared to those with 
common duct stones (10 [2.3%] of 438 patients).77 Of the 
three subjects in this study with no radiologic evidence of 
sphincter incompetence, one (subject #3) had been treated 
for presumed spasm of the sphincter, one (subject #4) for 
sphincter stenosis, and one (subject #5) for common duct 
stones. Despite complete relief of symptoms in all three 
subjects, restenosis of the papilla may have occurred, and 
this could account for the observed gallbladder filling in 
these individuals. 
Hospital records of the subjects in this study were 
reviewed to determine the estimated size of the papillotomy. 
Not surprisingly, this variable did not correlate with 
cholescintigraphic findings in this small series (see Table 
8). For example, the gallbladder visualized in subject #4 
despite a 1.5 cm incision, while no gallbladder filling 
occurred in subject #5, following a 1 cm papillotomy. 
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Incision size, however, is not a reliable indicator of the 
degree of sphincter ablation. The length of the choledochal 
sphincter in man varies greatly from individual to 
individual.12,174 Thus, while a small cut may totally sever 
the muscle in one person, another patient may retain some 
sphincter activity after a relatively large incision. 
Furthermore, in this series, papillotomy incision size was 
estimated visually, without the use of objective measuring 
techniques. Since all papillotomies were performed by the 
same endoscopist, these estimates are probably consistent, 
but the lack of objective data precludes drawing any 
conclusions based on incision length. 
Since papillotomy incision size has been shown to 
decrease over time,173 hospital records of the subjects in 
this study were reviewed to ascertain the time since papil¬ 
lotomy. This interval ranged from one to 21 months. No 
correlation of either scintigraphic or radiographic findings 
and post-papillotomy follow-up period was noted (see Table 
8), allowing no conclusions regarding the potential effects 
of sphincter healing on biliary physiology. 
The final variable measured in this study was the 
clinical outcome following endoscopic papillotomy. This also 
did not correlate with radiographic or scintigraphic 
findings. All subjects in this series claimed to have 
remained free of symptoms since papillotomy. Clinical 
improvement, however, provides very weak evidence of 
sphincter ablation, since this can be attributed to: 1) 
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partial loss of sphincter function, or 2) a placebo effect 
of interventional therapy.175 A placebo effect has been seen 
in patients treated with sham papillotomy in a randomized 
trial.167 
Possible Explanations for Gallbladder Nonvisualization: 
Gallbladder filling was not seen in three subjects in 
this study (50%). Besides the papillotomy, other factors 
which could account for a lack of gallbladder visualization 
include: 1) asymptomatic cystic duct obstruction, 2) chronic 
cholecystitis, and/or 3) a disorder of gallbladder motility. 
These conditions may have been present in two of these three 
subjects. Other reported causes of false positive cholescin- 
tigraphy (alcoholism, pancreatitis, severe intercurrent 
illness, hyperalimentation, prolonged fasting, and 
trauma)92 were present in none of these subjects. 
Cystic duct obstruction is possible in subject #2. On 
her initial ERCP the cystic duct and gallbladder did not 
opacify. Multiple abdominal radiographs taken during her 
period of hospitalization demonstrated one or more calcified 
gallstones in the region of the cystic duct and gallbladder 
neck. On her second ERCP, the cystic duct filled with 
contrast (see Figure 14B). The gallbladder was not seen, but 
no attempt was made to visualize it, once filling of the 
cystic duct became apparent. Although unlikely, occlusion at 
the neck of the gallbladder cannot be ruled out, since a 
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fully patent biliary tract has never been radiographically 
documented in this subject. However, one can also raise 
several arguments against cystic duct obstruction in this 
subject. First of all, it has already been stated that a 
lack of gallbladder filling on ERCP does not prove that the 
cystic duct is blocked.85 Bile stasis related to common duct 
obstruction can apparently produce the same finding. 
Secondly, serial abdominal films documented that the subject 
passed several stones from the gallbladder after papil¬ 
lotomy. Upon discharge, plain film revealed three calcified 
stones in the fundus of the gallbladder. On the day of the 
study only one gallstone was evident on plain film, and no 
stones were seen in the area of the cystic duct. Obviously, 
stones cannot leave the gallbladder if the cystic duct is 
occluded! In summary, the cystic duct must have been patent 
on at least several occasions in subject #2. The existence 
of a blocked cystic duct on the day of the study is 
unlikely, but this possibility cannot be ruled out. 
As described previously, chronic cholecystitis is a 
recognized cause of false positive cholescintiscans.92 * 94 
Both subjects with nonvisualized gallbladders demonstrated 
abnormal sonographic findings which have been associated 
with chronic cholecystitis. Subject #2 had a small gall¬ 
bladder and cholelithiasis, a common sonographic appearance 
of chronic cholecystitis.92*94 Subject #5 had a thickened 
gallbladder wall, measuring 6 mm (normal 2 mm or less92). 
The significance of this sonographic finding is unclear; 
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gallbladder wall thickening has been seen in several condi¬ 
tions, including acute and chronic cholecystitis, ascites, 
and gallbladder contraction following a meal9 2 * 1 7 6 * 1 7 7 
(subject #5 consumed a bowl of instant oatmeal four hours 
prior to her ultrasound examination). The presence of gall¬ 
stones places both of these subjects at risk for chronic 
cholecystitis. However, both subjects claimed to be free of 
symptoms of biliary disease since papillotomy. 
Studies have suggested that cholelithiasis is often 
associated with gallbladder dysmotility. One quantitative 
scintigraphic study noted diminished gallbladder filling in 
patients with gallstones as compared to controls.178 A later 
study, however, did not confirm this observation, but did 
demonstrate a decrease in mean gallbladder ejection fraction 
in patients with gallstones.179 One cannot attribute gall¬ 
bladder nonvisualization purely to the presence of gall¬ 
stones, since cholescintigraphy will visualize the gall¬ 
bladder in most patients with cholelithiasis. Indeed, if the 
mere existence of gallstones prevented gallbladder visual¬ 
ization, then scintigraphy would be no more useful than 
sonography in confirming a diagnosis of acute cholecystitis. 
Scintigraphic abnormalities seen in patients with chole¬ 
lithiasis must therefore be due to associated gallbladder 
dysfunction. In a recent study, Spengler et al.180 employed 
ultrasonography to measure parameters of gallbladder 
contraction (residual volume and ejection half-time, in 
response to CCK administration) in patients both before and 
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after gallstone fragmentation by extracorporeal shock-wave 
lithotripsy (ESWL). They found evidence of diminished gall¬ 
bladder motility in persons with gallstones as compared to 
controls, which remained unchanged one year after stone 
destruction by ESWL. Possible explanations for this 
observation include: 1) cholelithiasis causes a permanent 
disorder of gallbladder motility, 2) gallbladder dysmotility 
precedes and predisposes to stone formation, or 3) these two 
conditions share a common etiology. 
Another potential cause of gallbladder dysmotility is 
the autonomic neuropathy often seen in diabetes mellitus. 
Clinical studies have afforded evidence of impaired gall¬ 
bladder function in diabetics.181,182 As compared to non¬ 
diabetic controls, decreased gallbladder contraction 
following meals has been seen in female diabetic patients, 
even more commonly among those with diabetic autonomic 
neuropathy and retinopathy.181 Two of the three subjects 
whose gallbladder failed to visualize on scintigraphy are 
diabetics (#2 and #5, both females). According to subject 
#2's personal physician, she suffers from peripheral 
neuropathy, but has no symptoms of autonomic dysfunction. 
The possibility of a diabetic-induced biliary neuropathy 
contributing to gallbladder nonvisualization must be 
considered. Finally, if diabetic neuropathy can lead to 
functional denervation of the gallbladder, perhaps 
denervation of the sphincter of Oddi might also occur in 
some patients. This has not been described. No study has 
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evaluated baseline cholescintigraphic findings in diabetics. 
The potential presence of a chronically diseased 
gallbladder and/or disordered biliary motility, as well as 
the possibility of asymptomatic cystic duct obstruction, 
represent confounding variables which interfere with the 
interpretation of the data obtained in two subjects. Lack of 
gallbladder visualization on cholescintiscan cannot be 
attributed purely to a lack of sphincter of Oddi contrac¬ 
tion, especially in a study with such a small experimental 
group. In fact, one of these two subjects (#5) had no 
radiographic evidence of sphincter incompetence. Although 
this subject's gallbladder was seen on a prior cholescinti¬ 
scan in 1981, much could have occurred (such as progression 
of a biliary motility disorder) in the intervening eight 
years to account for the currently observed lack of gall¬ 
bladder filling. Unfortunately, a cholescintiscan performed 
one month before her papillotomy showed complete extra- 
hepatic obstruction, with no excretion of tracer from the 
liver at four hours post-injection, rendering assessment of 
the gallbladder and cystic duct impossible. In summary, the 
significance of these additional factors can only be 




The Role of the Sphincter of Oddi in Gallbladder Filling: 
A second objective of this investigation was to acquire 
further evidence regarding the importance of a functional 
sphincter of Oddi in the process of gallbladder filling in 
humans. Unfortunately, data on this topic are contradictory. 
The results of studies in subject #1 clearly demonstrate 
that gallbladder filling can occur even in the setting of a 
non-functional sphincter of Oddi. Sphincter incompetence in 
this subject was strongly suggested by the finding of 
biliary air on both plain abdominal film and ultrasono¬ 
graphy, and the demonstration of contrast reflux from the 
duodenum into the common bile duct, followed by rapid 
drainage of barium. These findings thus suggest that gall¬ 
bladder filling may depend upon other physiologic 
mechanisms, in addition to any role played by sphincter of 
Oddi contraction. However, in subject #6 nonvisualization of 
the gallbladder most likely occurred as a result of the loss 
of sphincter activity following endoscopic papillotomy, 
since the gallbladder was seen on a prior cholescintiscan 
done two days before the procedure. Studies in subject #6 
also showed evidence of sphincter incompetence (biliary air 
on both plain film and ultrasound). Findings in this subject 
thus imply a crucial role of the sphincter of Oddi in gall¬ 
bladder filling. These contrasting results can only be 
resolved by collecting additional data. 
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As described in the introduction, experimental data on 
the control of gallbladder filling are extremely variable 
(see Table 7 for an overall summary). While some studies 
clearly illustrate the importance of a passive filling 
mechanism, others suggest the possibility of an active role 
played by the gallbladder (perhaps in conjunction with the 
spiral valves of the cystic duct). Some of the contradictory 
results may be related to differences among the species 
studied. Biliary physiology probably varies in different 
animals. As previously mentioned, experiments in cats131 and 
rabbits152 suggest that a functional sphincter of Oddi is 
necessary for the gallbladder to fill. Studies in 
dogs,86'87,132'134,150'152 however, question the import of 
the sphincter in this process, with many investigators 
invoking contraction of the surrounding duodenal musculature 
as the force responsible for passive gallbladder 
filling.132-134,150 The study by Tansy et al.152 clearly 
demonstrated the importance of the terminal common bile duct 
in gallbladder filling in dogs, but showed that neither 
action of the sphincter nor the duodenal musculature was 
responsible for this effect. The actual force controlling 
the flow of bile into the gallbladder is not known. Contra¬ 
dictory results have also been found in humans, but these 
may be technique related. Jones and Smith70 noted non¬ 
visualization of the gallbladder on oral cholecystography in 
patients following sphincteroplasty, while Lempke135 
observed normal gallbladder filling after sphincterotomy. 
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This variability may have resulted from the existence of 
residual sphincteric activity. Sphincteroplasty usually 
produces total ablation of the sphincter of Oddi, while 
surgical sphincterotomy leaves part of the muscle intact.12 
Considering the results of numerous studies, as well as 
the observations in this investigation, it seems likely that 
gallbladder filling depends upon multiple physiologic 
factors. If so, a complete lack of gallbladder filling (as 
evidenced by nonvisualization of the gallbladder on chole- 
scintigraphy) may only occur in patients in whom all normal 
regulators of bile flow have been disrupted. As stated 
previously, gallbladder nonvisualization among the subjects 
in this study may not be related solely to a lack of 
sphincter activity, but rather to the combined effect of an 
ablated sphincter and an abnormal gallbladder. Two subjects 
in this study (#3 and #4) have never had documented gall¬ 
stones, but had endoscopic papillotomy performed because of 
sphincter of Oddi stenosis or spasm. The gallbladder filled 
in both of these subjects. It is possible that, in persons 
with normal gallbladder motility, the hypothetical active 
component of the filling process may alone be sufficient to 
fill the gallbladder, regardless of the functional integrity 
of the sphincter. Unfortunately, conclusions regarding the 
importance of sphincter activity in gallbladder filling in 
these two subjects may be unjustified, since neither had 
radiographic evidence of a patent papillotomy. 

116 
In order to truly ascertain the role of the sphincter 
of Oddi in gallbladder filling, an experimental model would 
have to hold other potential variables constant. In other 
words, determination of the relative contribution of 
sphincter activity to this process may require performing 
this study in persons with an otherwise normal biliary 
system. Of course, such a study would be impossible in 
humans, since endoscopists (hopefully) do not perform 
papillotomies on patients with a normal biliary system! 
However, it may be interesting to compare post-papillotomy 
scintigraphic findings in patients treated for sphincter of 
Oddi stenosis or spasm versus those treated for stone 
disease. This study included subjects from both of these 
groups, but the present numbers are insufficient to draw 
conclusions. Perhaps patients with isolated disorders of the 
sphincter of Oddi are more likely to have normal gallbladder 
function. It is unfortunate that this study did not employ a 
scintigraphic technique for measuring gallbladder ejection 
fraction,86*183 which would have assessed gallbladder 
motility in these subjects. This is an interesting prospect 
for future research. In persons whose gallbladder does not 
visualize on scintigraphy, gallbladder ejection fraction may 
be estimated by calculating gallbladder volume sonographi- 
cally both before and after administration of CCK.184 
Despite the small number of subjects, this study has 
clearly shown that gallbladder filling can occur in a 
patient in the presence of radiographically documented 
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sphincter incompetence. Thus, the sphincter of Oddi may not 
function as the sole regulator of bile flow into the gall¬ 
bladder. This information alone cannot determine whether the 
gallbladder fills by an active or passive mechanism. If 
occlusion of the terminal common bile duct is required for 
the gallbladder to fill, other physiological events, 
including constriction of the surrounding duodenal muscula¬ 
ture, or the action of some presently unknown mechanism 
(such as the "vascular dynamics of the ductal epithelium" 
proposed by Tansy152), may fulfill this purpose in persons 
lacking a functional sphincter of Oddi. Gall-bladder filling 
is probably influenced by several physiologic factors, 
including sphincter contraction, duodenal contraction, 
gallbladder motility, and possibly others. Elimination of 
only one of these variables may not result in a measurable 
physiologic effect. However, simultaneous interference with 
two or more potential controlling mechanisms may allow 
determination of the various forces responsible for 
gallbladder filling. It would be interesting to repeat this 
study in subjects with endo-scopically placed internal 
biliary stents.185'189 This would effectively eliminate any 
occlusive effect of both the sphincter and the duodenal 
musculature on the common bile duct. The occurrence of 
scintigraphic gallbladder visualization in subjects with 
biliary endoprostheses would provide a strong argument for 
an active filling process (provided it could be shown that 
the stent itself does not occlude the cystic duct). 
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Confounding factors may be present, however, since many 
patients receive these prosthetic devices for relief of 
malignant biliary obstruction. In such cases, the underlying 
disease may affect bile flow in the ducts and gallbladder. 
Stents are also used to maintain biliary drainage when 
stones cannot be removed186,189 (this was done in subject 
#2). Such persons are probably more suitable candidates for 
studies of bile flow. 
Hepatic Excretion of Radiopharmaceutical: 
An unexpected result of this study was the finding that 
five (83%) of six subjects demonstrated delayed hepatic 
excretion of radioisotope. This observation is in direct 
opposition to the expected results. In designing this study, 
it was assumed that most of the subjects would demonstrate 
unusually rapid clearance of tracer from the liver, due to 
the decreased resistance to bile flow out of the common 
duct. In patients with either common duct stones or papil¬ 
lary stenosis, isotope washout rates from the liver have 
been seen to increase in nearly all patients following 
papillotomy190,191 and after surgical biliary drainage.192 
This observation was noted in only one subject in this study 
(#2, see Figure 17B). It is not clear why excretion was 
delayed in the remaining five subjects. 
Quantitative cholescintigraphy has been shown to be 
highly sensitive in detecting derangements in hepatic 
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function. Abnormal liver uptake and clearance has been seen 
in various types of hepatobiliary disease, including acute 
viral hepatitis, intrahepatic cholestasis, and extrahepatic 
obstruction.191,192 Scintigraphic evidence of liver dys¬ 
function has also been observed in patients with normal 
serum liver function tests.191 This is precisely the 
situation seen in subjects #3 and #6. Liver function tests 
were not done as part of the experimental protocol, and thus 
were not available in the remaining four subjects. Although 
patients with intra- and extrahepatic cholestasis have shown 
an improvement in scintigraphically measured liver function 
following resolution of disease, quantitative indices do not 
always return to normal range.191,192 This might explain the 
observed derangements in hepatic function seen in five 
subjects. It is also possible that sphincter ablation 
somehow leads to impaired hepatic excretion. This has never 
been described, but the few studies on post-papillotomy 
scintigraphy have nearly exclusively involved patients with 
prior cholecystectomy. Perhaps the combined presence of a 
gallbladder and an ablated sphincter produces some as yet 
unknown detrimental effect on liver function. 
Finally, in using excretion curves to ascertain 
papillotomy patency, one must realize that measurement of 
hepatic clearance is only an indirect method of assessing 
flow resistance in the common duct. Delayed excretion of 
tracer from the liver may mask rapid drainage from the 
common bile duct. In the absence of extrahepatic obstruc- 
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tion, liver excretion may be the rate-limiting step in bile 
flow. Thus, even a widely gaping papillary orifice will not 
accelerate isotope clearance from a dysfunctional liver. A 
true measurement of the physiologic effect of a papillotomy 
would require quantification of clearance of tracer from the 
common bile duct. Although some researchers have encountered 
difficulty in distinguishing bile duct activity from that of 
the surrounding liver parenchyma,191 others have been able 
to quantify ductal bile flow by outlining regions of 
interest (ROI) over the common hepatic and common bile 
ducts. 1 5 4 * 1 7 9■ 193 However, since labelled bile must pass 
through the liver before entering the ductal system, 
impairments of hepatic function would also interfere with 
flow measurements in the bile ducts. A widely patent 
papilla may allow tracer to pass rapidly from the common 
duct into the duodenum, but this effect might be concealed 
by the prolonged period of entry into the duct from a 
diseased liver. 
The ability to discern rapid bile flow out of the 
common duct regardless of hepatic function would require a 
quantitative technique which either corrects for, or is 
independent of, abnormalities in the hepatic excretion rate. 
Stritzke et al.193 have described a computer algorithm based 
on substraction of background liver activity, which they 
have used to determine the time of appearance of tracer in 
the common duct in cases of biliary obstruction. It is not 
known whether they have used this method to assess duct 
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clearance after papillotomy. As an outgrowth of this 
research, a rapid frame "cine IDA scan" was developed 
(serial 1 minute images displayed in motion picture form), 
which can follow the flow of tracer down the common duct. 
This method is presently being evaluated as a means of 
measuring bile duct flow in normal individuals and those 
with known liver disease. A third possibility would involve 
determination of typical clearance parameters in regions of 
interest over the liver and common duct, in both normal 
individuals and persons with liver disease. This method 
should be able to illustrate whether altered hepatic 
excretion affects the measured washout of tracer from the 
duct, and may also generate a reliable correction factor for 
adjusting calculated common duct clearance in the presence 
of abnormal liver excretion. If either of these techniques 
proved successful, scintigraphy could offer a simple non- 
invasive method for estimating the adequacy of a papil¬ 
lotomy. As described, endoscopic biliary manometry is the 
current "gold standard" for evaluating sphincter of Oddi 
activity. As compared to an endoscopic procedure, a nuclear 
hepatobiliary scan is much more tolerable to patients, and 
less costly. Thus, assessment of biliary function after 





This investigation will continue. As additional 
patients with an intact gallbladder undergo endoscopic 
papillotomy, they will be invited to participate as 
research subjects. It may also be helpful to expand this 
study to include multiple centers, thus providing a larger 
population from which to draw subjects. With a sufficiently 
large sample size, the influence of confounding variables 
should be minimized, and a definitive answer to the question 
of gallbladder filling in persons after papillotomy may be 
obtainable. Furthermore, including the following studies in 
the experimental protocol may yield additional useful infor¬ 
mation: 1) measurement of gallbladder motility (ejection 
fraction in response to CCK), 2) quantification of tracer 
flow within a region of interest over the common bile duct 
(to directly assess drainage through the papillotomy), 3) 
measurement of pre- and post-papillotomy fasting gall¬ 
bladder volume by ultrasonography. 
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